<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Proteome Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Proteome Res</journal-id>
    <journal-id journal-id-type="publisher-id">pr</journal-id>
    <journal-id journal-id-type="coden">jprobs</journal-id>
    <journal-title-group>
      <journal-title>Journal of Proteome Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1535-3893</issn>
    <issn pub-type="epub">1535-3907</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9361347</article-id>
    <article-id pub-id-type="pmid">35654412</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jproteome.2c00020</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PPI-Affinity:
A Web Tool for the Prediction and Optimization
of Protein–Peptide and Protein–Protein Binding Affinity</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Romero-Molina</surname>
          <given-names>Sandra</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Ruiz-Blanco</surname>
          <given-names>Yasser B.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Mieres-Perez</surname>
          <given-names>Joel</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Harms</surname>
          <given-names>Mirja</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7316-7141</contrib-id>
        <name>
          <surname>Münch</surname>
          <given-names>Jan</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1927-260X</contrib-id>
        <name>
          <surname>Ehrmann</surname>
          <given-names>Michael</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath7">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9211-5803</contrib-id>
        <name>
          <surname>Sanchez-Garcia</surname>
          <given-names>Elsa</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Computational
Biochemistry, Center of Medical Biotechnology, <institution>University of Duisburg-Essen</institution>, Essen 45141, <country>Germany</country></aff>
      <aff id="aff2"><label>‡</label>Institute
of Molecular Virology, <institution>Ulm University Medical
Center</institution>, Ulm 89081, <country>Germany</country></aff>
      <aff id="aff3"><label>§</label>Core
Facility Functional Peptidomics, <institution>Ulm University
Medical Center</institution>, Ulm 89081, <country>Germany</country></aff>
      <aff id="aff4"><label>∥</label>Faculty
of Biology, Center of Medical Biotechnology, <institution>University of Duisburg-Essen</institution>, Essen 45141, <country>Germany</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>elsa.sanchez-garcia@uni-due.de</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>02</day>
      <month>06</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>05</day>
      <month>08</month>
      <year>2022</year>
    </pub-date>
    <volume>21</volume>
    <issue>8</issue>
    <fpage>1829</fpage>
    <lpage>1841</lpage>
    <history/>
    <permissions>
      <copyright-statement>© 2022 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0007" id="ab-tgr1"/>
      </p>
      <p>Virtual screening
of protein–protein and protein–peptide
interactions is a challenging task that directly impacts the processes
of hit identification and hit-to-lead optimization in drug design
projects involving peptide-based pharmaceuticals. Although several
screening tools designed to predict the binding affinity of protein–protein
complexes have been proposed, methods specifically developed to predict
protein–peptide binding affinity are comparatively scarce.
Frequently, predictors trained to score the affinity of small molecules
are used for peptides indistinctively, despite the larger complexity
and heterogeneity of interactions rendered by peptide binders. To
address this issue, we introduce PPI-Affinity, a tool that leverages
support vector machine (SVM) predictors of binding affinity to screen
datasets of protein–protein and protein–peptide complexes,
as well as to generate and rank mutants of a given structure. The
performance of the SVM models was assessed on four benchmark datasets,
which include protein–protein and protein–peptide binding
affinity data. In addition, we evaluated our model on a set of mutants
of EPI-X4, an endogenous peptide inhibitor of the chemokine receptor
CXCR4, and on complexes of the serine proteases HTRA1 and HTRA3 with
peptides. PPI-Affinity is freely accessible at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://protdcal.zmb.uni-due.de/PPIAffinity">https://protdcal.zmb.uni-due.de/PPIAffinity</uri>.</p>
    </abstract>
    <kwd-group>
      <kwd>machine learning</kwd>
      <kwd>mutation</kwd>
      <kwd>dissociation
constant</kwd>
      <kwd>peptide design</kwd>
      <kwd>protein−protein
interaction</kwd>
      <kwd>binding free energy</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>3115/11-1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>SFB 1430</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>SFB 1279</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EXC-2033</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EH 100/18-1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CRC 1430</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Deutsche Forschungsgemeinschaft</institution>
            <institution-id institution-id-type="doi">10.13039/501100001659</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CRC 1279</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>pr2c00020</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>pr2c00020</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Protein–protein
interactions (PPIs) are fundamental to most
biological processes.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Prominent disorders,
such as cancer and degenerative diseases, are related to aberrant
PPIs.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> In therapy, optimized PPIs are also
critical for the strong binding of antibodies to their protein antigens.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Therefore, the characterization of PPIs in terms
of their binding affinity (BA) is highly relevant to the design of
new biologics and therapeutic compounds.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Notably, peptides are a promising class of bioactive compounds,
which often have higher specificity and reduced side effects compared
to small-molecule pharmaceuticals.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Currently,
there are more than 60 approved peptide drugs, and hundreds of peptidic
compounds undergo clinical or preclinical trials.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> However, the design of peptide drugs remains a challenging
task due to their flexible structures and diversity of binding sites.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p>
    <p>Virtual screening approaches, based on
BA predictions, reduce the
time of the drug development pipelines.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Thus, over the past decades, several screening tools based on the
BA of protein–protein complexes have been introduced.<sup><xref ref-type="bibr" rid="ref8">8</xref>−<xref ref-type="bibr" rid="ref26">26</xref></sup> Relevant examples of these methods are DFIRE,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> CP_PIE,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> ISLAND,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and the web server PRODIGY,<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> (which tailored and improved the original model introduced by Kastritis
et al.).<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Protein–peptide complexes
are usually scored with functions derived from binding affinity data
of small molecules. Examples of such scoring methods are RF-Score<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> and Kdeep,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> which
used a random forest algorithm<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> and a
convolutional neural network,<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref32">32</xref></sup> respectively, to train
their models. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-1</ext-link> summarizes the above-mentioned BA predictors, as well as other state-of-the-art
methods that contribute to the broad field of PPI prediction tools.</p>
    <p>Noteworthy, to the best of our knowledge, there is no publicly
available web tool <bold>specifically</bold> designed to predict and
optimize the BA of diverse protein–peptide complexes, by considering
as a peptide an amino acid sequence with less than 30 residues. Several
works have approached this aim specifically for the identification
of binders of the major histocompatibility complexes MHC-I, II.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> However, given that their training is restricted to MHC data, these
models are not applicable to predict the binding free energy of other
protein–peptide complexes. Besides, the available tools typically
do not leverage the possibility of optimizing the primary structure
of the peptide to improve the affinity of the complex.</p>
    <p>We evaluated
the performance of the above-mentioned screening tools
for estimating the BA of protein–peptide complexes by testing
100 randomly selected protein–peptide complexes from the Biolip<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> database. This test set contained complexes
with peptides ranging from 4 to 29 amino acids, coupled to receptors
with sizes between 51 and 496 amino acids. The binding free energy
of the complexes covered the range between −12.6 and −4.6
kcal/mol. The highest correlation was delivered by Kdeep (<italic>R</italic> = 0.32), while the correlation with all of the other methods
was in the range <italic>R</italic> = [0.13, 0.24] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-2</ext-link>). This comparison evidences
the rather low dependability of state-of-the-art screening tools for
the prediction of the BA of protein–peptide complexes.</p>
    <p>Given the remarkable scaffold that peptides represent for drug
development, we addressed this issue by developing machine-learning-based
predictors of BA that are specific for protein–peptide complexes.
In addition, we present a predictor of protein–protein BA that
rivals the performance of the state-of-the-art screening tools built
for such systems. Both predictors are integrated into a novel tool
named PPI-Affinity, which is a web server designed to score protein–protein
and protein–peptide complexes based on their predicted BA,
as well as to optimize the affinity of a complex by mutating and screening
selected residues. With such functionalities, PPI-Affinity can be
employed at early steps of drug design processes, which are focused
on the screening and optimization of protein/peptide binders for a
given protein target.</p>
  </sec>
  <sec id="sec2">
    <title>Materials and Methods</title>
    <p>In this section,
we describe the dataset and the modeling procedure
used to develop both predictors. In both scenarios, protein–protein
and protein–peptide systems, the performance of the models
is evaluated with cross-validation and hold-out test sets.</p>
    <sec id="sec2.1">
      <title>Data Collection:
Protein–Protein Complexes</title>
      <p>We
initially retrieved 2 852 protein–protein complexes with known
BA data deposited in the PDBbind (v.2020)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> database. Subsequently, we curated these data by extracting only
dimeric complexes and removed those in common with the benchmark used
by Vangone and Bonvin<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> to assess their
model. We excluded those cases in which the binding affinity values
were reported with measures other than <italic>K</italic><sub>d</sub>, <italic>K</italic><sub>i</sub>, or Δ<italic>G</italic><sub>bind</sub>. Likewise, those instances with imprecise BA values (<italic>i.e.</italic>, reporting ranges of <italic>K</italic><sub>d</sub> values instead of precise values) were removed. Cases with binding
free energy values outside the range [−18.1, −3.1] kcal/mol
were also excluded, as these instances are sparingly represented and
the difference between their BA value and the rest of the distribution
was Δ<italic>G</italic> ≥ 0.5. The application of such
filters rendered a dataset of 833 protein–protein complexes
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-1</ext-link> depicts
the distribution of binding free energy values for this dataset).
All of the structures were preprocessed by adding hydrogens and other
missing atoms with MODELLER v9.23<sup><xref ref-type="bibr" rid="ref37">37</xref>−<xref ref-type="bibr" rid="ref40">40</xref></sup> and PDB2PQR.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup></p>
    </sec>
    <sec id="sec2.2">
      <title>Features Generation</title>
      <p>We employed
the 3D-structure descriptors
implemented in the protein codification package ProtDCal.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> This program is accessible via the web server
ProtDCal-Suite,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> which also provides access
to other models developed by us using this codification approach.
ProtDCal has a workflow of four automated steps, which are: (i) residue-wise
codification, (ii) modification based on the vicinity, (iii) residue
grouping based on amino acid types, and (iv) numerical aggregation
using descriptive statistics. The options selected at each step are
used in a combinatorial scheme to generate an array of numerical descriptors
that characterize the input structure. Each descriptor in the array
is the result of the combination of one residue property (e.g., reside-wise
contact order, RWCO),<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> a vicinity operator
(e.g., autocorrelation, AC), a grouping criterion (e.g., nonpolar
residues, NPR), and an aggregation operator (e.g., variance, V); thus,
every element in the array is identified by a unique label (e.g.,
RWCO_AC_NPR_V). In the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-1</ext-link>, we provide the configuration file used to compute
the descriptors employed in this study. This configuration generates
23 040 descriptors for each protein–protein complex.
In ProtDCal, interchain residue contacts are determined by a maximum
spatial distance (<italic>d</italic>) measured between the α
carbons of the residues. We set up the calculation of such contacts
with a spatial cutoff <italic>d</italic> = 10 Å. ProtDCal has
been successfully applied by us and other authors to model post-translational
modifications,<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup> protein–protein interaction,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> enzyme-like amino acid sequences,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> critical
residues for protein function,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> and antibacterial
peptides.<sup><xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p>
    </sec>
    <sec id="sec2.3">
      <title>Modeling Protocol for Protein–Protein
Affinity Data</title>
      <p>The learning process was carried out with Weka
3.8.4.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Support Vector Machine (SVM) was
selected as
the learning algorithm after performing a preliminary study that showed
that it is the simplest and best-performing solution for developing
the models (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-2</ext-link>). SVM is a successful approach widely validated in drug discovery.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> This technique has delivered a worthy performance on small and mid-sized
datasets,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> where deeper machine learning
(ML) approaches, such as various neural network architectures, tend
to overfit.<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref></sup> The implementation of SVM for
regression in the package SMOreg<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> was
employed to develop the models. We randomly split the collected data
into three datasets: a training set with 653 complexes, a development
set with 90 complexes, and a test set with 90 complexes (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_002.zip">Script SI-1</ext-link>). The purpose of the development
set was to monitor the generalization of multiple configurations of
the hyperparameters during the training process. The hold-out test
set was exclusively used to compare the final model with external
predictors.</p>
      <p>Initially, every instance in the training set was
represented as a vector of 23 040 molecular descriptors generated
with ProtDCal. The steps of feature selection included the removal
of invariant descriptors and those carrying missing values. Next,
an optimal subset of attributes was searched with a supervised exploration
guided by the error in the prediction of the binding affinity for
cases in the training set. The resulting optimal subset comprised
26 descriptors, which were used to train the final models (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-3</ext-link>). <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_002.zip">Supporting Information File SI-1</ext-link> provides a configuration
file for ProtDCal to compute this specific list of descriptors.</p>
      <p>We adopted an ensemble learning approach by creating four partially
overlapping subsets of the training data with a distribution of the
output variable flatter than the complete training set (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-2</ext-link>). Thus, we
trained independent models with each subset and combined their outcomes
using the Vote method implemented in Weka 3.8.4,<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> with combination schemes based on the average,
maximum, and minimum predicted values among selected models.</p>
      <p>With each training subset, the hyperparameters of the SVM were
adjusted using a grid search.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> The search
space was defined by the following range of hyperparameter values:<list list-type="bullet"><list-item><p>Complexity (<italic>C</italic>):
2<sup>–5</sup>, 2<sup>–4.5</sup>, 2<sup>–4</sup>, 2<sup>–3.5</sup>, 2<sup>–3</sup>,..., 2<sup>1</sup>, 2<sup>1.5</sup>, 2<sup>2</sup>, 2<sup>2.5</sup>, 2<sup>3</sup>,
2<sup>3.5</sup> and 2<sup>4</sup></p></list-item><list-item><p>Degree
(<italic>D</italic>) of the polynomial function
kernel: 1, 2, and 3</p></list-item></list></p>
      <p>The models generated
during the search were assessed using the
Pearson’s correlation coefficient (<italic>R</italic>) (<xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>) of the estimations in
the training data via resubstitution and 10-fold cross-validation
(10-fold CV), as well as in the development set.<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_m001" position="anchor"/><label>1</label></disp-formula>The terms <italic>y</italic><sub><italic>i</italic></sub> and <italic>y̅</italic> are the actual affinity values
and their mean in the datasets. Analogously, the terms <italic>y</italic><sub><italic>i</italic></sub><sup arrange="stack">pred</sup> and <italic>y̅</italic><sup>pred</sup> correspond
to the same type of values but as predicted by the model.</p>
      <p>To
identify the optimum values of the hyperparameters, we formulated
an <italic>ad hoc</italic> fitness-robustness score (FRS) (<xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>) as a function of the
correlation coefficient, which combines in a single measure the performance
of a model in terms of goodness of fit and robustness. The FRS function
has an optimum maximum value at FRS = 1; thus, we selected the configuration
that maximized the FRS function.<disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_m002" position="anchor"/><label>2</label></disp-formula></p>
      <p>The
terms <italic>R</italic><sub>TS</sub>, <italic>R</italic><sub>CV</sub>, and <italic>R</italic><sub>DEV</sub> are the correlation
coefficients obtained on the training set, in 10-fold CV, and development
set, respectively. <italic>R̅</italic> is the arithmetic mean
of the performance on these three tests. The first term of the function
aims to combine the performance on the training set (goodness of fit),
with the performance in cross-validation and development set (generalization).
The next two terms reduce the deviations between the performance on
the training set and the performance when evaluating in cross-validation
and development set. These weighting terms improve the robustness
of the selected model by considering the generalization power of the
predictor in addition to the goodness of fit. Overall, such a unified
quantity is a highly informative measure to guide the optimization
of hyperparameters during the modeling. We intend to continue challenging
this formulation in further studies and applications. <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> summarizes the results of
the optimization of the hyperparameter values in each training subset.
A complete list of all of the intermediate models and performance
measures is provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-3</ext-link>.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Results of the optimization of hyperparameters. The selected
model
per training subset is marked with a red square and corresponds to
the combination of degree (<italic>D</italic>) and complexity (log<sub>2</sub> <italic>C</italic>) values that maximized the fitness-robustness
score defined in <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0002" id="gr1" position="float"/>
      </fig>
      <p>All possible combinations with
at least two models were evaluated
in the development set to determine the best ensemble model. We summarized
all of the performance measures for the independent models and the
distinct ensembles in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-4</ext-link>.</p>
    </sec>
    <sec id="sec2.4">
      <title>Data Collection: Protein–Peptide Complexes</title>
      <p>The
model was developed with data extracted from the Biolip database,
which also incorporates data from the PDBbind Protein-Ligand<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> database. We downloaded the nonredundant dataset
of Biolip, containing 105 152 entries. Only protein–peptide
complexes with less than 90% of identity between the binding site′s
residues and the full receptor sequence are included in these data.
We extracted the complexes containing single-chain receptor only and
a peptide formed by standard residues with a minimum length of three
residues. Instances reported with post-translational modifications
or fusion constructs (peptide/nonpeptide) were discarded. Subsequently,
we selected the cases for which their BA values are reported in terms
of the dissociation (<italic>K</italic><sub>d</sub>) or inhibition
(<italic>K</italic><sub>i</sub>) constants only. We excluded the complexes
with ambiguous <italic>K</italic><sub>d</sub> or <italic>K</italic><sub>i</sub> values (<italic>i.e.</italic>, reporting a range of
values), and those with binding free energies outside the range from
−14.4 to −3.6 kcal/mol<underline>,</underline> as these
instances were poorly represented and the difference between their
BA value and the rest of the distribution was Δ<italic>G</italic> ≥ 0.5. The curated dataset contained 1149 complexes, with
peptides of length ranging between 3 and 29 amino acids and receptors
of sizes between 31 and 957 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-3</ext-link>). Hydrogen atoms and other missing
atoms were added to the structures using MODELLER v9.23<sup><xref ref-type="bibr" rid="ref37">37</xref>−<xref ref-type="bibr" rid="ref40">40</xref></sup> and PDB2PQR.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup></p>
    </sec>
    <sec id="sec2.5">
      <title>Modeling Protocol for the
Protein–Peptide BA Data</title>
      <p>We used SVM, implemented in
the package SMOreg<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> in Weka 3.8.4, following
a protocol equivalent to that
employed for the protein-protein model described above. In summary,
we randomly divided the dataset into three subsets: training dataset
(949 instances), development dataset (100 instances), and test dataset
(100 instances) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_002.zip">Script SI-1</ext-link>). Subsequently,
we extracted numerical descriptors from the complexes’ structure
using ProtDCal<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> with the configuration file summarized
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-1</ext-link>.
This step generated 23 040 molecular descriptors for each instance
in the dataset. Next, we reduced this large multidimensional space
to 37 descriptors through a features selection process (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-4</ext-link>; a list of
the extracted set of descriptors can be found in the file <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">SI-2</ext-link>).</p>
      <p>The training scheme used to develop
the final predictor followed an ensemble approach. Four individual
models were built with partially overlapping subsets of the training
set. The subsets are random samples of the training data with a flatter
distribution of the BA values (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-4</ext-link>) compared to the entire training set. This is achieved
by undersampling the region next to the mode value of the distribution,
while keeping the tails. Such transformation in the distribution of
the data allows a balanced error weight along the entire range of
the response variable. Subsequently, we optimized the hyperparameters
of each model independently and combined their predictions with the
Vote method implemented in Weka 3.8.4, according to the average, maximum,
and minimum ensemble rules.</p>
      <p>To create the models, the hyperparameters
of the estimator were
adjusted in a grid search following the same methodology as for the
protein–protein model. During the optimization of the hyperparameters,
the performance of the models was monitored in the training data,
in 10-fold CV, and the development set. The optimum set of hyperparameter
values for each training dataset was selected according to the FRS
defined in <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> shows the results
of the hyperparameters tuning process for each training subset. A
complete list of all of the intermediate models and performance measures
can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-5</ext-link>.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Results of the optimization of hyperparameters. The selected model
per training subset is marked with a red square and corresponds to
the combination of degree (<italic>D</italic>) and complexity (log<sub>2</sub> <italic>C</italic>) values that maximized the FRS.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0003" id="gr2" position="float"/>
      </fig>
      <p>Next, the best ensemble model was selected by evaluating
all possible
combinations of models on the development set (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-6</ext-link>). The selected ensemble
model was evaluated on the hold-out test set of 100 complexes and
compared with other available state-of-the-art protein–protein
and protein–ligand BA predictors. Finally, the ranking power
of the model was assessed on a set of mutants of the peptide EPI-X4,
an endogenous inhibitor of CXCR4 whose activity was experimentally
determined and on a set of complexes between peptides and the serine
proteases HTRA1 or HTRA3.</p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results and Discussion</title>
    <p>In this section, we analyze the performance of the developed models
and compare them with other state-of-the-art predictors.</p>
    <sec id="sec3.1">
      <title>Performance
of the Protein–Protein Model</title>
      <p>The
best ensemble model contains two out of the four training subsets,
whose individual correlations are <italic>R</italic><sub>2</sub> = <italic>R</italic><sub>3</sub> = 0.50. The ensemble model improved the individual
ones achieving a correlation of <italic>R</italic> = 0.53 on the development
set. The rule of minimum predicted value was used to build the ensemble
predictor.</p>
      <p>Recently, Vangone and Bonvin<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> developed a model that predicts the BA based on two structural descriptors:
the network of inter-residue contacts (ICs) and the noninteracting
surface (NIS). The model, named ICs/NIS-based predictor was implemented
in the web server PRODIGY.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> This tool
delivered a much better performance (<italic>R</italic> = 0.74 and
MAE = 1.4) than other state-of-the-art methods on a benchmark set
of 79 protein–protein complexes. Thus, we employed this benchmark
set to evaluate our method (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, Test set 1) against the ICs/NIS-based model, the
other two top-ranked and currently available tools in that assessment,
and the ISLAND method. We estimated the performance of our ensemble
model on this benchmark set and obtained a correlation coefficient <italic>R</italic> = 0.62 and MAE = 1.8 kcal/mol (Test set 1) that ranks
our method second, after PRODIGY.</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Summary of the Evaluation
of PPI-Affinity
and State-of-the-Art BA Predictors on Two Sets of Protein–Protein
Affinity Data<xref rid="t1fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="left"> </th>
              <th colspan="2" align="center" char=".">test
set 1<hr/></th>
              <th colspan="2" align="center" char=".">test
set 2<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center" char=".">
                <italic>R</italic>
              </th>
              <th style="border:none;" align="center" char=".">MAE (kcal/mol)</th>
              <th style="border:none;" align="center" char=".">
                <italic>R</italic>
              </th>
              <th style="border:none;" align="center" char=".">MAE (kcal/mol)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">PRODIGY</td>
              <td style="border:none;" align="char" char=".">0.74</td>
              <td style="border:none;" align="char" char=".">1.4</td>
              <td style="border:none;" align="char" char=".">0.31</td>
              <td style="border:none;" align="char" char=".">2.5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DFIRE</td>
              <td style="border:none;" align="char" char=".">0.60</td>
              <td style="border:none;" align="char" char=".">4.6</td>
              <td style="border:none;" align="char" char=".">0.10</td>
              <td style="border:none;" align="char" char=".">25.4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CP_PIE</td>
              <td style="border:none;" align="char" char=".">–0.52</td>
              <td style="border:none;" align="char" char=".">8.8</td>
              <td style="border:none;" align="char" char=".">–0.10</td>
              <td style="border:none;" align="char" char=".">11.0</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">ISLAND</td>
              <td style="border:none;" align="char" char=".">0.38</td>
              <td style="border:none;" align="char" char=".">2.1</td>
              <td style="border:none;" align="char" char=".">0.27</td>
              <td style="border:none;" align="char" char=".">2.2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PPI-Affinity</td>
              <td style="border:none;" align="char" char=".">0.62</td>
              <td style="border:none;" align="char" char=".">1.8</td>
              <td style="border:none;" align="char" char=".">0.50</td>
              <td style="border:none;" align="char" char=".">1.8</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t1fn1">
            <label>a</label>
            <p>The performance is expressed as
the Pearson’s correlation coefficient (<italic>R</italic>)
between experimental and predicted BA. The test set 1 corresponds
to the benchmark employed by Vangone and Bonvin,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> while the test set 2 corresponds to the hold-out set of
90 data points taken from PDBbind (v.2020). The performance for the
other methods on test set 1 was reported by Vangone and Bonvin.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> The negative values of the correlation coefficients
indicate that the corresponding method predicts unbinding free energy.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Next, we challenged the predictors
with a larger hold-out test
set of 90 complexes, which was initially extracted from the data collected
from the PDBbind (v.2020) protein–protein dataset (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, test set 2). In
this test, our model renders a correlation coefficient of <italic>R</italic> = 0.50, with an error MAE = 1.8 kcal/mol (Test set 2),
performance which is only marginally inferior to that obtained in
the benchmark set of Vangone and Bonvin<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> (<italic>R</italic> = 0.62; MAE = 1.8 kcal/mol). The performance
of ISLAND was diminished with respect to our method. Nevertheless,
ISLAND delivered consistent results, in general superior to those
delivered by other methods, in both test sets. The other predictors
(PRODIGY, DFIRE, CP_PIE) show a large decrease in their performance
with respect to their results in the test set 1 (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, test set 1), with PRODIGY
being the second best with a correlation coefficient <italic>R</italic> = 0.31 and MAE = 2.5 kcal/mol. Such a dramatic decay in the predictions
suggests the presence of overfitting toward the previous benchmark
set, specifically in the case of PRODIGY. Nonetheless, the analysis
of the performance of the other predictors is hindered by the lack
of applicability domain (AD) definition for using the methods. The
absence of a defined AD limits the analysis of the errors of the predictions,
as it is not possible to examine whether test samples are simply outside
the scope of these predictors or there is a specific structural issue
that affects the quality of the prediction.</p>
      <p>In short, the data
evidence the generalization achieved by our
predictor, which performs consistently well in different external
test sets. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-5</ext-link> displays plots of experimental versus predicted BA values for PPI-Affinity
in both test sets.</p>
      <p>Next, we evaluated the performance of PPI-Affinity
on a set of
mutants taken from the SKEMPI v2.0<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> dataset
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). This database
reports the binding affinity changes of 7085 mutations of 345 protein–protein
interactions for which the structure of the complex has been resolved.
We selected a subset from this dataset by applying the following filtering
steps: (I) we extracted the dimeric complexes having at least 30 amino
acids in each protein sequence; (II) we removed the complexes overlapping
between the selected data, the PDBbind (v.2020) dataset, and the benchmark
set of Vangone and Bonvin;<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> and (III)
we removed the wild-type systems with more than one binding affinity
value reported, as well as all mutants with ambiguous or unreported
binding affinities. The output of the filtering steps reduced the
dataset to 34 wild-type complexes and 182 mutants. We fed the conformed
test set to PPI-Affinity. Eight wild-type complexes and their related
mutants were found outside the applicability domain of the model.
Thus, the final test set contained 26 wild-type structures and 151
mutants. The assessed mutants featured between one and six mutations
per protein sequence, with 80% of the structures accounting for only
one mutation. The binding free energy of all of the complexes was
in the range of −16.3 to −5.5 kcal/mol.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Performance of PPI-Affinity
on the test set of 26 wild-type complexes
and 151 mutants of protein–protein affinity data points taken
from the SKEMPI dataset. The performance is reported as the Pearson’s
correlation coefficient (<italic>R</italic>) between experimental
and predicted BA. The green points correspond to BA values of the
wild-type complexes, and the orange points correspond to the BA values
of the mutants.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0004" id="gr3" position="float"/>
      </fig>
      <p>The performance of PPI-Affinity
(<italic>R</italic> = 0.78 and
MAE = 1.4 kcal/mol) on the SKEMPI dataset is superior to that obtained
in the Vangone and Bonvin benchmark<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, Test set 1) and
in the 90 protein–protein complexes taken from the PDBbind
(v.2020) database (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, Test set 2). When considering only the wild-type complexes,
PPI-Affinity delivered a performance of <italic>R</italic> = 0.77
and MAE = 1.1 kcal/mol. These results evidence the robustness of our
protein–protein model in a third external dataset, at the time
that show the ability of PPI-Affinity to characterize the changes
upon mutations of protein–protein complexes.</p>
      <p>Additionally,
we assessed the performance of PPI-Affinity against
the LUPIA<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> classifier. LUPIA uses a threshold
value to classify as “high” or “low” the
binding affinity of protein–protein complexes. This evaluation
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-5</ext-link>) evidenced
the shortcomings of discretizing the BA values to train classifiers
rather than regressors models. Taken together, the performance of
our protein–protein model on several tests ranks our ensemble
model on the top of state-of-the-art fast protein–protein BA
predictors.</p>
    </sec>
    <sec id="sec3.2">
      <title>Performance of the Protein–Peptide
Model</title>
      <p>The
best ensemble model was obtained by two out of the four training subsets,
improving their performances (<italic>R</italic><sub>1</sub> = 0.53, <italic>R</italic><sub>3</sub> = 0.54) to <italic>R</italic> = 0.56 on the
development set. The rule of maximum value was used to build the ensemble
model. The model was assessed on the test set of 100 protein–peptide
complexes initially hold-out from the data extracted from the Biolip
database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Figure SI-6</ext-link>). Here, we compared the results of our method with state-of-the-art
protein–protein and protein–ligand BA predictors. The
considered tools include Kdeep and RF-Score for protein–ligand
complexes, as well as the above-presented PRODIGY, DFIRE, and CP_PIE
methods. ISLAND requires a minimum size of 20 amino acids for each
protein sequence. For this reason, the tool was applied to the assessment
of only the protein–protein model.</p>
      <p>Our protein–peptide
affinity model outperformed all the other tools, showing a correlation
coefficient of <italic>R</italic> = 0.55 with MAE = 1.1 kcal/mol (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). The low correlations
values delivered by other state-of-the-art tools can be related to
the fact that the functions of Kdeep and RF-Score are fitted primarily
using small organic ligands.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref64">64</xref></sup> This suggests that
fitting with mostly small ligand data cannot capture the differences
imposed by the larger size of the peptides, as well as the diversity
of peptide interactions with the target and the solvent.</p>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>Correlation Coefficient (R) of Protein–Protein
and Protein–Ligand BA Predictors on the Test Set of 100 Protein–Peptide
Complexes<xref rid="t2fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center" char=".">
                <italic>R</italic>
              </th>
              <th style="border:none;" align="center" char=".">MAE (kcal/mol)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">PRODIGY</td>
              <td style="border:none;" align="char" char=".">0.13</td>
              <td style="border:none;" align="char" char=".">1.9</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DFIRE</td>
              <td style="border:none;" align="char" char=".">0.29</td>
              <td style="border:none;" align="char" char=".">8.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CP_PIE</td>
              <td style="border:none;" align="char" char=".">–0.28</td>
              <td style="border:none;" align="char" char=".">9.0</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Kdeep*</td>
              <td style="border:none;" align="char" char=".">0.32</td>
              <td style="border:none;" align="char" char=".">10.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">RF-Score*</td>
              <td style="border:none;" align="char" char=".">0.23</td>
              <td style="border:none;" align="char" char=".">1.8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PPI-Affinity</td>
              <td style="border:none;" align="char" char=".">0.55</td>
              <td style="border:none;" align="char" char=".">1.1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t2fn1">
            <label>a</label>
            <p>Protein–ligand
methods are
marked with a star. The negative values of the correlation coefficients
indicate that the corresponding method predicts unbinding free energy.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="sec3.3">
      <title>Case Study I: Ranking the
Affinity of Mutants of EPI-X4</title>
      <p>EPI-X4 (Endogenous Peptide
Inhibitor of CXCR4) is a fragment of albumin
identified as an endogenous antagonist of the CXC chemokine receptor
4 (CXCR4) by Zirafi et al.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> Given the
implication of CXCR4 in viral (HIV) infection, inflammation and cancer,<sup><xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref67">67</xref></sup> this peptide represents a highly promising scaffold to develop therapeutic
drugs targeting the CXCR4 receptor.</p>
      <p>Recently, mutants of EPI-X4
have been screened to identify derivatives with enhanced stability
and affinity. For this, the affinity values (in terms of IC<sub>50</sub> nanomolar, nM) of EPI-X4 and 56 derivatives to CXCR4 were estimated
using an antibody competition assay.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> The
scheme of this assay is based on the competitive binding of a fluorescently
labeled anti-CXCR4 antibody (clone 12G5) with CXCR4 ligands (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-6</ext-link>).<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> These derivatives are peptides with size in
the range of 6–16 amino acids. From the experiments, 26 mutants
out of 30 active (IC<sub>50</sub> &lt; 10 000nM) derivatives
were found to be more active compared to EPI-X4. Here, we employed
these data to evaluate the ranking power of our protein–peptide
affinity model. For doing this, we use the enrichment factor (EF<italic><sub>I</sub></italic>),<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> defined as (<xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>):<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_m003" position="anchor"/><label>3</label></disp-formula>where <italic>I</italic> represents a fixed
number of top-ranked instances based on predicted values; <italic>N</italic><sub>active</sub><sup arrange="stack">top<sub><italic>i</italic></sub></sup> is the number of active peptides,
within the top <italic>I</italic> instances of the dataset; <italic>N</italic><sub>active</sub> is the number of <italic>active</italic> peptides; and <italic>N</italic><sub>total</sub> is the total number
of peptides in the whole dataset. Peptides with IC<sub>50</sub> &lt;
10 000 nM were defined as active for an initial test. In a
second and more stringent evaluation, the <italic>active</italic> peptides
were considered as those more active than EPI-X4.</p>
      <p>The structures
of the complexes, formed by CXCR4 and each peptide
mutant, were generated via homology modeling using as a template the
structural model of the complex CXCR4/EPI-X4, reported by Sokkar et
al.<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref></sup> We estimated the BA of each complex with
different predictors, as well as the associated enrichment factors.</p>
      <p><xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref> shows the
results of the tests corresponding to (1) the conventional activity
test using the activity threshold determined by the competition assay
(IC<sub>50</sub> = 10 000 nM) and (2) the peptides with an
affinity higher than EPI-X4. PPI-Affinity achieved the maximum enrichment
EF<sub>5</sub> = EF<sub>10</sub> = EF<sub>15</sub> = 1.9 for this
test, <italic>i.e.</italic>, the 15 top-ranked instances according
to the PPI-Affinity estimation are active. In the case of the stringent
test, taking only those with higher affinity than EPI-X4 as active,
the maximum EF was obtained within the top 10 peptides, i.e., EF<sub>5</sub> = EF<sub>10</sub> = 1.9, while the enrichment within the
top 15 derivatives also reached a high value EF<sub>15</sub> = 1.8.
The high enrichment factor within the top 5, 10, and 15 peptides,
representing more than 25% of the dataset, evidenced the remarkable
ranking capabilities of PPI-Affinity. The other tools show moderate
to high enrichment values although below the level reached by PPI-Affinity
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). Noteworthy
are CP_PIE and Kdeep, which deliver a steady high performance in the
different tests.</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Performance of protein–protein and protein–ligand
BA predictors on the set of 56 derivatives of EPI-X4. The performance
of the methods is based on the enrichment factor (EF) obtained among
the top 5, 10, and 15 ranked candidates. Two results are shown per
tool, one corresponding to the activity test (AT), and the second
corresponding to the peptides with an affinity higher than EPI-X4
(AT<sub>EPI-X4</sub>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec3.4">
      <title>Case Study II: Ranking the Affinity of Peptides for the PDZ
Domains of HtrAs</title>
      <p>High-temperature requirement serine proteases
(HtrAs) are involved in many physiological processes and neurodegenerative
diseases such as Alzheimer’s disease and CARASIL.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> These proteases are largely regulated by an
allosteric mechanism whose initial step is the interaction of polypeptide
chains with the peripheric PDZ domain. Here, we challenged PPI-Affinity
with a series of peptides bound to PDZ domains of two human HtrAs:
HTRA1 and HTRA3.</p>
      <p>For these sets of protein–peptide interactions,
we compared the relative ranking based on the binding affinity predicted
by PPI-Affinity to the ranking based on the experimentally determined
IC<sub>50</sub> values<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> (<xref rid="tbl3" ref-type="other">Tables <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="tbl4" ref-type="other">4</xref>).</p>
      <table-wrap id="tbl3" position="float">
        <label>Table 3</label>
        <caption>
          <title>Ranking of BA of Protein–Peptide
Interactions in HTRA1 as Predicted by PPI-Affinity and Based on the
Experimental IC<sub>50</sub> Values<xref rid="t3fn3" ref-type="table-fn">c</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="left"/>
            <col align="char" char="±"/>
          </colgroup>
          <thead>
            <tr>
              <th colspan="2" align="center">PPI-Affinity<hr/></th>
              <th colspan="2" align="center">experimental<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="center">ranking</th>
              <th style="border:none;" align="center" char=".">Δ<italic>G</italic> (kcal/mol)</th>
              <th style="border:none;" align="center">ranking</th>
              <th style="border:none;" align="center" char="±">(IC50 (μM))<xref rid="t3fn1" ref-type="table-fn">a</xref></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">(1) DSAIWWV</td>
              <td style="border:none;" align="char" char=".">–8.8</td>
              <td style="border:none;" align="left">(1) <bold>DSRIWWV</bold></td>
              <td style="border:none;" align="char" char="±">0.9 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(2) GWKTWIL</td>
              <td style="border:none;" align="char" char=".">–8.5</td>
              <td style="border:none;" align="left">(2) DARIWWV</td>
              <td style="border:none;" align="char" char="±">1.3 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(3) WDKIWHV</td>
              <td style="border:none;" align="char" char=".">–8.2</td>
              <td style="border:none;" align="left">(3) DSAIWWV</td>
              <td style="border:none;" align="char" char="±">2.5 ± 0.4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(4) <bold>DSRIWWV</bold></td>
              <td style="border:none;" align="char" char=".">–8.1</td>
              <td style="border:none;" align="left">(4) WDKIWHV</td>
              <td style="border:none;" align="char" char="±">2.8 ± 0.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(5) DARIWWV</td>
              <td style="border:none;" align="char" char=".">–8.0</td>
              <td style="border:none;" align="left">(5) ASRIWWV</td>
              <td style="border:none;" align="char" char="±">2.8 ± 0.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(6) ASRIWWV</td>
              <td style="border:none;" align="char" char=".">–8.0</td>
              <td style="border:none;" align="left">(6) DSRIWWA</td>
              <td style="border:none;" align="char" char="±">3.5 ± 0.9</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(7) DIETWLL</td>
              <td style="border:none;" align="char" char=".">–7.8</td>
              <td style="border:none;" align="left">(7) DSRIWAV</td>
              <td style="border:none;" align="char" char="±">6 ± 1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(8) DSRIWWA</td>
              <td style="border:none;" align="char" char=".">–7.3</td>
              <td style="border:none;" align="left">(8) GWKTWIL</td>
              <td style="border:none;" align="char" char="±">7.7 ± 0.6</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(9) DSRAWWV</td>
              <td style="border:none;" align="char" char=".">–7.3</td>
              <td style="border:none;" align="left">(9) DSRAWWV</td>
              <td style="border:none;" align="char" char="±">13 ± 1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(10) DSRIWAV</td>
              <td style="border:none;" align="char" char=".">–7.2</td>
              <td style="border:none;" align="left">(10) DIGPVCFL</td>
              <td style="border:none;" align="char" char="±">16 ± 3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(11) DIGPVCFL<xref rid="t3fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–7.1</td>
              <td style="border:none;" align="left">(11) DIETWLL</td>
              <td style="border:none;" align="char" char="±">23 ± 3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(12) EVKIMVV<xref rid="t3fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–7.0</td>
              <td style="border:none;" align="left">(12) EVKIMVV</td>
              <td style="border:none;" align="char" char="±">24 ± 8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(13) DSRIAWV</td>
              <td style="border:none;" align="char" char=".">–6.9</td>
              <td style="border:none;" align="left">(13) DSRIAWV</td>
              <td style="border:none;" align="char" char="±">40 ± 5</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t3fn1">
            <label>a</label>
            <p>Values taken from ref (<xref ref-type="bibr" rid="ref72">72</xref>).</p>
          </fn>
          <fn id="t3fn2">
            <label>b</label>
            <p>Protein–peptide
structures
that are at the border of the applicability domain of PPI-Affinity.</p>
          </fn>
          <fn id="t3fn3">
            <label>c</label>
            <p>No protein–peptide structure
is outside the applicability domain.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Ranking of BA of Protein–Peptide
Interactions in HTRA3 as Predicted by PPI-Affinity and Based on the
Experimental IC<sub>50</sub> Values</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="left"/>
            <col align="char" char="±"/>
          </colgroup>
          <thead>
            <tr>
              <th colspan="2" align="center">PPI-Affinity<hr/></th>
              <th colspan="2" align="center">experimental<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="center">ranking</th>
              <th style="border:none;" align="center" char=".">Δ<italic>G</italic> (kcal/mol)</th>
              <th style="border:none;" align="center">ranking</th>
              <th style="border:none;" align="center" char="±">(IC50 (μM))<xref rid="t4fn1" ref-type="table-fn">a</xref></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">(1) FGAWV<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–7.7</td>
              <td style="border:none;" align="left">(1) <bold>FGRWV</bold></td>
              <td style="border:none;" align="char" char="±">0.6 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(2) <bold>FGRWV</bold><xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–7.5</td>
              <td style="border:none;" align="left">(2) RSWWV</td>
              <td style="border:none;" align="char" char="±">0.6 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(3) FGRWI<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–7.5</td>
              <td style="border:none;" align="left">(3) FGAWV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">0.9 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(4) RSWWV</td>
              <td style="border:none;" align="char" char=".">–7.4</td>
              <td style="border:none;" align="left">(4) FGRWI<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">1.0 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(5) FGRWF<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–7.3</td>
              <td style="border:none;" align="left">(5) GRWV</td>
              <td style="border:none;" align="char" char="±">1.0 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(6) GRWV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–7.2</td>
              <td style="border:none;" align="left">(6) FARWV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">1.1 ± 0.2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(7) FGRWA<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–7.1</td>
              <td style="border:none;" align="left">(7) RWV</td>
              <td style="border:none;" align="char" char="±">1.3 ± 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(8) FGRAV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–6.9</td>
              <td style="border:none;" align="left">(8) FGRWL</td>
              <td style="border:none;" align="char" char="±">2.9 ± 0.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(9) FGRWL<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–6.6</td>
              <td style="border:none;" align="left">(9) FGRWA</td>
              <td style="border:none;" align="char" char="±">3.5 ± 0.3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(10) WV<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–6.6</td>
              <td style="border:none;" align="left">(10) WV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">4.7 ± 0.4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(11) WA<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–6.5</td>
              <td style="border:none;" align="left">(11) FGRWF<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">7.7 ± 0.8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(12) FARWV<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–6.4</td>
              <td style="border:none;" align="left">(12) WA<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">14 ± 1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(13) WG<xref rid="t4fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="char" char=".">–6.2</td>
              <td style="border:none;" align="left">(13) WG<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char="±">22 ± 3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">(14) RWV<xref rid="t4fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="char" char=".">–5.2</td>
              <td style="border:none;" align="left">(14) FGRAV</td>
              <td style="border:none;" align="char" char="±">270 ± 110</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t4fn1">
            <label>a</label>
            <p>Values from ref (<xref ref-type="bibr" rid="ref72">72</xref>).</p>
          </fn>
          <fn id="t4fn2">
            <label>b</label>
            <p>Protein–peptide structures
are at the border of the applicability domain of PPI-Affinity.</p>
          </fn>
          <fn id="t4fn3">
            <label>c</label>
            <p>Protein–peptide structures
that are outside the applicability domain of PPI-Affinity.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The prediction of PPI-Affinity suggests
that three of the peptides
have more affinity for the PDZ domain of HTRA1 than the experimentally
determined best binder DSRIWWV (in bold, <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). However, the calculated binding affinities
of those peptides differ from that of DSRIWWV by only 0.1, 0.4, and
0.7 kcal/mol (for WDKIWHV, GWKTWIL, and DSAIWWV, respectively). These
differences are very small and within the MAE of PPI-Affinity (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>).</p>
      <p>The rest
of the peptides are correctly predicted by the method
as weaker binders than DSRIWWV to the PDZ domain of HTRA1. We note,
however, that the binding energy differences for most of these peptides
also fall within the MAE reported for our method based on the test
set of protein–peptide affinity (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p>
      <p>Interestingly, even the two peptides
(DIGPVCFL and EVKIMVV) at
the border of the applicability domain of our method are correctly
predicted as weaker binders to the PDZ domain of HTRA1 compared to
DSRIWWV. Nevertheless, the predicted values for peptides that are
outside the applicability domain of PPI-Affinity should be considered
with care. The <italic>K</italic><sub>d</sub> of the complex between
HTRA1 and DSRIWWV is experimentally reported as 1.3 ± 0.2 μM,
which corresponds to Δ<italic>G</italic> = −8.2 ±
0.1 kcal/mol at the experimental temperature of 301.15 K. This value
is in excellent agreement with the value of −8.1 kcal/mol predicted
by PPI-Affinity (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p>
      <p>We also tested our method on peptides binding to the PDZ
domain
of HTRA3 (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>).
In this set of protein–peptide complexes, eight systems are
outside the applicability domain of PPI-Affinity.</p>
      <p>As shown in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>, only one peptide
(FGAWV) is incorrectly predicted to have better
BA for HTRA3 than the best experimental binder FGRWV. We note that
FGRWV lies outside the applicability domain of the model, and this
prediction should be taken with caution.</p>
      <p>In addition, we measured
the overall ranking power of PPI-Affinity
by calculating Kendall’s correlation coefficient<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> on both test sets, HTRA1 and HTRA3 protein–peptide
complexes (<xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>).
The results obtained with PRODIGY, Kdeep, RF-Score, DFIRE, and CP_PIE
are also shown for comparison. The binding affinity values delivered
by each tool are listed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Section SI-7</ext-link>.</p>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Correlation of IC<sub>50</sub> Values
with the Estimations from PPI-Affinity and Other State-of-the-Art
BA Predictors on the Sets of HTRA1’s and HTRA3’s PDZ
Binders</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="left"> </th>
              <th colspan="2" align="center" char=".">
                <italic>R</italic>
                <hr/>
              </th>
              <th colspan="2" align="center" char=".">τ<hr/></th>
            </tr>
            <tr>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center" char=".">HTRA1</th>
              <th style="border:none;" align="center" char=".">HTRA3</th>
              <th style="border:none;" align="center" char=".">HTRA1</th>
              <th style="border:none;" align="center" char=".">HTRA3</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">PRODIGY</td>
              <td style="border:none;" align="char" char=".">0.25</td>
              <td style="border:none;" align="char" char=".">
                <bold>0.29</bold>
              </td>
              <td style="border:none;" align="char" char=".">0.18</td>
              <td style="border:none;" align="char" char=".">0.01</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">DFIRE</td>
              <td style="border:none;" align="char" char=".">0.59</td>
              <td style="border:none;" align="char" char=".">0.24</td>
              <td style="border:none;" align="char" char=".">0.38</td>
              <td style="border:none;" align="char" char=".">0.15</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CP_PIE</td>
              <td style="border:none;" align="char" char=".">–0.11</td>
              <td style="border:none;" align="char" char=".">–0.03</td>
              <td style="border:none;" align="char" char=".">–0.25</td>
              <td style="border:none;" align="char" char=".">–0.08</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Kdeep*</td>
              <td style="border:none;" align="char" char=".">0.38</td>
              <td style="border:none;" align="char" char=".">0.11</td>
              <td style="border:none;" align="char" char=".">0.16</td>
              <td style="border:none;" align="char" char=".">0.41</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">RF-Score*</td>
              <td style="border:none;" align="char" char=".">0.56</td>
              <td style="border:none;" align="char" char=".">0.13</td>
              <td style="border:none;" align="char" char=".">0.56</td>
              <td style="border:none;" align="char" char=".">0.27</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">PPI-Affinity</td>
              <td style="border:none;" align="char" char=".">
                <bold>0.63</bold>
              </td>
              <td style="border:none;" align="char" char=".">0.02</td>
              <td style="border:none;" align="char" char=".">
                <bold>0.59</bold>
              </td>
              <td style="border:none;" align="char" char=".">
                <bold>0.42</bold>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Kendall’s tau coefficient is a robust nonparametric
measure
highly suitable to discriminate correlated from uncorrelated variables.
This measure involves two main magnitudes: the number of concordant
and discordant pairs. Two observations (<italic>x</italic><sub><italic>i</italic></sub>, <italic>y</italic><sub><italic>i</italic></sub>) and (<italic>x</italic><sub><italic>j</italic></sub>, <italic>y</italic><sub><italic>j</italic></sub>) are classified as a concordant pair
if <italic>x</italic><sub><italic>i</italic></sub> &gt; <italic>x</italic><sub><italic>j</italic></sub>, and <italic>y</italic><sub><italic>i</italic></sub> &gt; <italic>y</italic><sub><italic>j</italic></sub>, or vice versa <italic>x</italic><sub><italic>i</italic></sub> &lt; <italic>x</italic><sub><italic>j</italic></sub> and <italic>y</italic><sub><italic>i</italic></sub> &lt; <italic>y</italic><sub><italic>j</italic></sub>. If none of these conditions are true, the pair is known as
discordant.</p>
      <p>The Kendall’s tau correlation coefficient
(τ) is defined
as (<xref rid="eq4" ref-type="disp-formula">eq <xref rid="eq4" ref-type="disp-formula">4</xref></xref>)<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_m004" position="anchor"/><label>4</label></disp-formula>where <italic>N</italic><sub>c</sub> and <italic>N</italic><sub>d</sub> are the
number of concordant and discordant
pairs, respectively; <italic>N</italic><sub>t</sub> is the number
of ties in the order of the binding affinity determined by PPI-Affinity;
and <italic>N</italic><sub>u</sub> is the number of ties in the experimental
binding affinity. The Kendall’s correlation coefficient is
equal to 1 if the calculated ranking of the peptides completely agrees
with the ranking determined experimentally.</p>
      <p>Importantly, here
we correlate IC<sub>50</sub> values with predicted
binding free energy changes; these magnitudes are expected to be linked
by a nonlinear relation, which then violates the linearity requirement
for the proper interpretation of Pearson’s correlation coefficient.
Besides, the small size of the data induces violations of the bivariate
normality requisite of this coefficient. Consequently, the use of
a robust nonparametric measure such as Kendall’s tau coefficient
is a requirement to achieve a correct interpretation of the correlation
tests.</p>
      <p>The Pearson’s correlation coefficient obtained
by PPI-Affinity
(<italic>R</italic> = 0.02) in the HTRA3 test set evidences the lack
of correlation with the experimentally measured IC<sub>50</sub> values.
Beyond the previously noted shortcomings of Pearson’s coefficient
to assess these data, this result can be also a consequence of half
of the peptides in the test set being outside the applicability domain
of PPI-Affinity. For HTRA1 binders, where all cases are within the
applicability domain, PPI-Affinity delivers the highest correlation
coefficient value (<italic>R</italic> = 0.63).</p>
      <p>In terms of Kendall’s
tau coefficient, PPI-Affinity produces
the highest values for both targets (τ = 0.59 and τ =
0.42 for HTRA1 and HTRA3, respectively), evidencing its better ranking
power compared to other state-of-the-art predictors. Interestingly,
RF-Score gives the second-best performance on the HTRA1 test set with
τ = 0.56, which is diminished by about half on the HTRA3 test
set (τ = 0.27). Conversely, Kdeep’s performance is close
to PPI-Affinity’s on the HTRA3 test set (τ = 0.41), but
Kdeep delivers the lowest positive Kendall’s tau value on the
HTRA1 test set (τ = 0.16). The weak performance of PRODIGY on
both test sets might be related to the limitations of its protein–protein
affinity predictor to evaluate smaller protein–peptide complexes.
An important advantage of PPI-Affinity is that, thanks to two tailored
models for protein–protein and protein–peptide complexes,
PPI-Affinity can deliver comparable performance levels for both types
of biomolecular systems.</p>
      <p>In short, the evaluation of BA predictors
on different tests and
test sets evidenced that state-of-the-art BA predictors, either intended
for protein–protein or protein–ligand complexes, deliver
low accuracy in the prediction of the BA of protein–peptide
complexes. Although it improves the accuracy of the state-of-the-art
approaches only slightly, PPI-Affinity is a solution to that issue
since it delivers a significantly better and robust performance among
different tests. This fact tackles the inherent issues in generalization
and overfitting that apparently affect other predictors. The shortcomings
in the accuracy of predictions of absolute binding free energy values
are to a large extent a consequence of the inherent deviations in
the experimental data available for training, which arise from uneven
standards under the experimental conditions and measurement procedures.
Nonetheless, within such a noisy scenario, the support vector machine
models developed by us allow making predictions that improve to some
extent the state of the art at the same time of showing steady performance
in both absolute binding affinity prediction and ranking assessments.</p>
    </sec>
    <sec id="sec3.5">
      <title>Web Server Implementation</title>
      <p>We implemented PPI-Affinity
as a web server to facilitate the use of our models. PPI-Affinity
is a suite organized in three modules, which are summarized below
by order of increasing complexity of their functionality.</p>
      <sec id="sec3.5.1">
        <title>Binding Affinity
Predictor</title>
        <p>This method is the direct
application of the prediction models in a set of PDB files with protein–protein
and protein–peptide complexes that should be provided by the
users. The module has the functionality to characterize diverse complexes,
whose structures were obtained from external sources, based on their
binding affinity.</p>
      </sec>
      <sec id="sec3.5.2">
        <title>Build &amp; Predict</title>
        <p>This module
follows the same purpose
as the previous one. However, instead of receiving coordinate files
with the complexes of interest, it only requires a template file (in
PDB format) and a list of amino acid sequences (in FASTA format).
Then, the server builds five structural homology models for each sequence
in the list, using MODELLER, and selects the structure with the lowest
DOPE as the best candidate to represent the complex. Subsequently,
it scores all the complexes using the predictor of binding affinity.
The Build &amp; Predict module is particularly suitable for screening
structurally similar complexes for which no structure has been elucidated.</p>
      </sec>
      <sec id="sec3.5.3">
        <title>Protein Engineering</title>
        <p>This third and most comprehensive
module allows for the automatic generation and scoring of mutations
at the interface of the complexes, which aims to optimize the affinity
of these complexes. <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> depicts the workflow of the module, which encompasses the
next steps:</p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Workflow of the three modules included in PPI-Affinity. For each
module, the required input data and associated steps are indicated.
The main difference among them lies in the input data: the <italic>Binding Affinity predictor</italic> module receives as input a set
of protein–protein/peptide complexes (in PDB format); the <italic>Build &amp; Predict</italic> module generates the complexes from
a template file and a list of amino acid sequences (in FASTA format)
provided by the user; and the <italic>Protein Engineering</italic> module receives as input only a template model, generates a list
of derivatives for one of the protein/peptide contained in the PDB
file, and calculates homology models for all created mutants. Regardless
of the module, once the PDB files have been prepared, PPI-Affinity
computes the structural descriptors with ProtDCal, estimates the BA
values with the machine learning models, and returns the list of derivatives
ranked by their BA values.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_0006" id="gr5" position="float"/>
        </fig>
        <sec id="sec3.5.3.1">
          <title>Step
1: Template Input</title>
          <p>The user provides an input structure
of the complex (in PDB format) and optionally the amino acid sequences
of the chains in FASTA format. In addition, the user must specify
which chain will be optimized.</p>
        </sec>
        <sec id="sec3.5.3.2">
          <title>Step 2: Mutants Generation</title>
          <p>Next, a maximum of 10 000
derivatives is constructed for the specified chain. The generation
of mutants is controlled by the following parameters: the maximum
number of modifications to the reference sequence, deletion and mutation
probabilities, maximum molecular weight, type of mutations, and a
mutability vector whose elements take value 0 for residues that remain
unmodified and a value between 0 and 1 representing the probability
of modifying each position. The types of mutations are defined by
groups of amino acids; the types are “Conservative”
formed by the groups Polar (NCQHSTG), Acid (DE), Basic (KR), Non-polar
(AILMPV), and Aromatic (WYF) residues; “Conservative extended”
for Polar extended (NCQHSTGDEKR) and Non-polar extended (AILMPVWYF)
residues; and “Unrestrained” allows the residues to
be changed by any other type of residue.</p>
        </sec>
        <sec id="sec3.5.3.3">
          <title>Step 3: Homology Modeling</title>
          <p>In this step, five structural
models per derivative are generated with MODELLER. Among them, the
structure with the lowest DOPE value is selected as the best model
for the corresponding mutant.</p>
        </sec>
        <sec id="sec3.5.3.4">
          <title>Step 4: BA Estimation</title>
          <p>The binding free energy is calculated
using either the protein–protein or the protein–peptide
affinity predictor. The selection of the estimator depends on the
lengths of the chains in the structure; if a chain contains less than
30 residues, the protein–peptide predictor is used, otherwise
the protein–protein estimator is applied.</p>
        </sec>
        <sec id="sec3.5.3.5">
          <title>Step 5:
Ranking of Mutants</title>
          <p>Finally, the mutants will
be arranged in decreasing or increasing order of affinity, and either
all or a selection of top candidates are returned to the user. The
two sorting schemes allow the use of this module not only as an optimizer
of the complex but also to spot mutations that can largely destabilize
the complex of interest.</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec3.6">
      <title>Applicability Domain</title>
      <p>Defining the applicability domain
(AD) of a model is an important step before the deployment of a predictor
as it allows to provide insights into the reliability of the estimations
in new systems.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> Here, the AD is the subspace
defined by the value range of the variables of the models (structural
descriptors) in our training dataset (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Tables SI-7 and SI-8</ext-link>). Thus, the descriptors’
value of a new complex is checked to determine whether this structure
is within the AD of the model. The result of this analysis is provided
to the users alongside the predicted binding affinity value. Estimations
associated with instances outside the AD should be interpreted with
special care and probably corroborated by other methods. Additionally, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Table SI-9</ext-link> summarizes
the sizes of the peptides and receptors used to train and test the
protein–peptide model. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">Supporting Information Tables SI-10 and SI-11</ext-link> present the descriptive statistics of
the training, development, and test sets used in the modeling.</p>
    </sec>
    <sec id="sec3.7">
      <title>Implementation
Details</title>
      <p>The frontend of PPI-Affinity
was implemented with the Python Framework Django v3.1.1 for uploading
and validating the user data. The backend, which constitutes the core
of the program, was programmed in Python 3. Internally, PPI-Affinity
uses MODELLER<sup><xref ref-type="bibr" rid="ref37">37</xref>−<xref ref-type="bibr" rid="ref40">40</xref></sup> to create the new homology structures. ProtDCal<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> is used to calculate the structural descriptors required
by the SVM models, and Weka 3.8.4<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> is
the interpreter of these predictors to predict the binding free energy
of the generated structures. Finally, a queuing system is employed
for the management of the jobs sent by the users.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Conclusions</title>
    <p>We developed PPI-Affinity, a binding free energy predictor targeting
protein–protein and protein–peptide complexes specifically.
This fast-screening tool moderately outperformed the predictions and
ranking power of similar empirical predictors. The performance of
the models was evaluated on various test sets, which include a largely
used benchmark set for empirical binding free energy predictors and
scoring functions, as well as new augmented datasets gathered in this
work from BioLip and PDBbind. We also evaluated the ranking power
of the protein–peptide model on a set of EPI-X4 derivatives
and HtrAs peptide binders. Altogether, these tests highlight PPI-Affinity,
not only as a top-ranked predictor but also as the most robust tool
with respect to performance in different tests.</p>
    <p>Furthermore,
we implemented our models in a freely available web
server that incorporates diverse functionalities that allow the screening
of protein complexes as well as the engineering of the amino acid
composition at the interface of the complex, to enhance the binding
affinity or to spotlight critical mutants that may destabilize the
interaction. The PPI-Affinity web server is thus a versatile tool
with a direct impact on the design of peptide binders as well as in
protein engineering and design.</p>
  </sec>
</body>
<back>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jproteome.2c00020?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jproteome.2c00020</ext-link>.<list id="silist" list-type="simple"><list-item><p>Setup of parameters
used for the calculation of the
structural descriptors (Supporting Information Section SI-1); preliminary
study of Machine Learning (ML) techniques (Supporting Information
Section SI-2); feature selection process for the protein–protein
BA modeling (Supporting Information Section SI-3); feature selection
process for the protein–peptide BA modeling (Supporting Information
Section SI-4); evaluation of PPI-Affinity and a state-of-the-art classifier
(Supporting Information Section SI-5); assays used to determine the
BA of EPI-X4 derivatives against the CRCX4 receptor (Supporting Information
Section SI-6); generation and ranking of peptide binders to the PDZ
domains of HTRA1 and HTRA3 (Supporting Information Section SI-7);
tabular description of PPI-Affinity and other state-of-the-art PPI
prediction tools (Supporting Information Table SI-1); correlation
coefficient (<italic>R</italic>) of BA predictors on the test set
of 100 protein–peptide complexes (Supporting Information Table
SI-2);
performance of intermediate models for the protein–protein
BA modeling during the hyperparameters tuning process (Supporting
Information Table SI-3); performance of individual and ensemble models
for the protein–protein complexes (Supporting Information Table
SI-4); performance of the intermediate models for the protein–peptide
modeling during the hyperparameters tuning process (Supporting Information
Table SI-5); performance of individual and ensemble models for the
protein–peptide complexes (Supporting Information Table SI-6);
applicability domain of the protein–protein model (Supporting
Information Table SI-7); applicability domain of the protein–peptide
model (Supporting Information Table SI-8); minimum and maximum values
of the sequences’ length of peptides and proteins (Supporting
Information Table SI-9); descriptive statistics of the protein–protein
data sets (Supporting Information Table SI-10); descriptive statistics
of the protein–peptide data sets (Supporting Information Table
SI-11); distribution of Δ<italic>G</italic> bind values in the
dataset of protein–protein complexes (Supporting Information
Figure SI-1); distribution of Δ<italic>G</italic> bind values
in the datasets of the protein–protein ensemble model (Supporting
Information Figure SI-2); characterization of the dataset of protein–peptide
complexes (Supporting Information Figure SI-3); distribution of Δ<italic>G</italic> bind values in the datasets of the protein–peptide
ensemble model (Supporting Information Figure SI-4); plots of experimental
vs predicted on the test sets of protein–protein BA data (Supporting
Information Figure SI-5); plot of experimental vs predicted on the
test set of protein–peptide BA data (Supporting Information
Figure SI-6) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>Python script used to randomly split the datasets into
training, development, and test subsets (Script SI-1); configuration
file for ProtDCal to compute the descriptors of the protein–protein
model (File SI-1); configuration file for ProtDCal to compute the
descriptors of the protein–peptide model (File SI-2); binding
affinity predictions of PPI-Affinity and state-of-the-art tools on
the benchmark of 79 protein–protein complexes employed by Vangone
and Bonvin<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> (File SI-3); binding affinity
predictions of PPI-Affinity and state-of-the-art tools on the hold-out
set of 90 protein–protein complexes taken from PDBbind (v.2020)
(File SI-4); binding affinity predictions of PPI-Affinity and state-of-the-art
tools on the hold-out set of 177 (26 wild-type and 151 mutants) protein–protein
complexes taken from the SKEMPI v2.0 dataset (File SI-5); binding
affinity predictions of PPI-Affinity and state-of-the-art tools on
the hold-out set of 100 protein–peptide complexes taken from
the Biolip database (File SI-6); binding affinity predictions of PPI-Affinity
and other state-of-the-art tools on the test set of protein–peptide
complexes containing EPI-X4 and 56 derivatives coupled to the CXCR4
receptor (File SI-7); and summary of the protein–protein and
protein–peptide complexes used in the training, validation,
and test of the PPI-Affinity models (File SI-8) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00020/suppl_file/pr2c00020_si_002.zip">ZIP</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_si_001.pdf">
        <caption>
          <p>pr2c00020_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="sifile2">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00020_si_002.zip">
        <caption>
          <p>pr2c00020_si_002.zip</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-2">
    <title>Author Contributions</title>
    <p>S.R.-M.,
Y.B.R.-B., and E.S.-G. designed the project. S.R.-M. implemented the
codes, performed the machine learning analyses and part of the validation
tests, and built the webserver. J.M.-P. carried out the HtrAs validation
tests. Y.B.R.-B. and E.S.-G. supervised the modeling and implementation
of the method. S.R.-M., J.M.-P., Y.B.R.-B., and E.S.-G. wrote the
manuscript. M.H. carried out the antibody competition assays. J.M.
supervised the experiments and the synthesis of the peptides, and
both, J.M. and M.H., contributed to the analysis of the experimental
data. M.E. contributed HtrAs expertise. All authors contributed to
revising and editing the manuscript. All authors have given approval
to the final version of the manuscript.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d7e2506-autogenerated">
    <p>The authors declare
no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work
was funded by the Deutsche Forschungsgemeinschaft
(DFG, German Research Foundation)-Project ID: 436586093 and the SFB
1430 “Molecular Mechanisms of Cell State Transitions”,
subprojects B04 and A06. E.S.-G. was also supported by the DFG under
Germany’s Excellence Strategy-EXC-2033-Project number 390677874.
E.S.-G., S.R.-M., M.J., and J.M. acknowledge the SFB 1279 “Exploiting
the Human Peptidome for Novel Antimicrobial and Anticancer Agents”,
subproject A06, funded by the DFG. E.S.-G. and J.M.-P. thank Dr. Melisa
Merdanovic for useful discussions. J.M. also acknowledges funding
by the DFG (3115/11–1). M.E. was supported by the Deutsche
Forschungsgemeinschaft EH 100/18–1. M.H. received project start-up
funding via the “Bausteinprogramm” of the Medical Faculty
and via the Gender Equality Program for female scientists of Ulm University.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Lu</surname><given-names>H.</given-names></name>; <name><surname>Zhou</surname><given-names>Q.</given-names></name>; <name><surname>He</surname><given-names>J.</given-names></name>; <name><surname>Jiang</surname><given-names>Z.</given-names></name>; <name><surname>Peng</surname><given-names>C.</given-names></name>; <name><surname>Tong</surname><given-names>R.</given-names></name>; <name><surname>Shi</surname><given-names>J.</given-names></name><article-title>Recent advances
in the development
of protein–protein interactions modulators: mechanisms and
clinical trials</article-title>. <source>Signal Transduction Targeted
Ther.</source><year>2020</year>, <volume>5</volume>, <fpage>213</fpage><pub-id pub-id-type="doi">10.1038/s41392-020-00315-3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Blazer</surname><given-names>L. L.</given-names></name>; <name><surname>Neubig</surname><given-names>R. R.</given-names></name><article-title>Small Molecule Protein–Protein
Interaction Inhibitors
as CNS Therapeutic Agents: Current Progress and Future Hurdles</article-title>. <source>Neuropsychopharmacology</source><year>2009</year>, <volume>34</volume>, <fpage>126</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2008.151</pub-id>.<pub-id pub-id-type="pmid">18800065</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Al
Qaraghuli</surname><given-names>M. M.</given-names></name>; <name><surname>Kubiak-Ossowska</surname><given-names>K.</given-names></name>; <name><surname>Ferro</surname><given-names>V. A.</given-names></name>; <name><surname>Mulheran</surname><given-names>P. A.</given-names></name><article-title>Antibody-protein
binding and conformational changes: identifying allosteric signalling
pathways to engineer a better effector response</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume>, <elocation-id>13696</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-70680-0</pub-id>.<pub-id pub-id-type="pmid">32792612</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Hill</surname><given-names>T. A.</given-names></name>; <name><surname>Shepherd</surname><given-names>N. E.</given-names></name>; <name><surname>Diness</surname><given-names>F.</given-names></name>; <name><surname>Fairlie</surname><given-names>D. P.</given-names></name><article-title>Constraining Cyclic
Peptides To Mimic Protein Structure Motifs</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2014</year>, <volume>53</volume>, <fpage>13020</fpage>–<lpage>13041</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201401058</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Lau</surname><given-names>J. L.</given-names></name>; <name><surname>Dunn</surname><given-names>M. K.</given-names></name><article-title>Therapeutic
peptides: Historical perspectives, current
development trends, and future directions</article-title>. <source>Bioorg.
Med. Chem.</source><year>2018</year>, <volume>26</volume>, <fpage>2700</fpage>–<lpage>2707</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2017.06.052</pub-id>.<pub-id pub-id-type="pmid">28720325</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Henninot</surname><given-names>A.</given-names></name>; <name><surname>Collins</surname><given-names>J. C.</given-names></name>; <name><surname>Nuss</surname><given-names>J. M.</given-names></name><article-title>The Current
State of Peptide Drug
Discovery: Back to the Future?</article-title>. <source>J. Med. Chem.</source><year>2018</year>, <volume>61</volume>, <fpage>1382</fpage>–<lpage>1414</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b00318</pub-id>.<pub-id pub-id-type="pmid">28737935</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Wang</surname><given-names>S. H.</given-names></name>; <name><surname>Yu</surname><given-names>J.</given-names></name><article-title>Structure-based design
for binding peptides in anti-cancer therapy</article-title>. <source>Biomaterials</source><year>2018</year>, <volume>156</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.11.024</pub-id>.<pub-id pub-id-type="pmid">29182932</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Horton</surname><given-names>N.</given-names></name>; <name><surname>Lewis</surname><given-names>M.</given-names></name><article-title>Calculation of the
free energy of association for protein complexes</article-title>. <source>Protein Sci.</source><year>1992</year>, <volume>1</volume>, <fpage>169</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1002/pro.5560010117</pub-id>.<pub-id pub-id-type="pmid">1339024</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name><article-title>A physical reference
state unifies the structure-derived potential of mean force for protein
folding and binding</article-title>. <source>Proteins: Struct., Funct.,
Bioinf.</source><year>2004</year>, <volume>56</volume>, <fpage>93</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20019</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Cheng</surname><given-names>T. M.-K.</given-names></name>; <name><surname>Blundell</surname><given-names>T. L.</given-names></name>; <name><surname>Fernandez-Recio</surname><given-names>J.</given-names></name><article-title>pyDock: Electrostatics
and desolvation
for effective scoring of rigid-body protein–protein docking</article-title>. <source>Proteins: Struct., Funct., Bioinf.</source><year>2007</year>, <volume>68</volume>, <fpage>503</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1002/prot.21419</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Pierce</surname><given-names>B.</given-names></name>; <name><surname>Weng</surname><given-names>Z.</given-names></name><article-title>ZRANK: Reranking protein docking predictions with an optimized energy
function</article-title>. <source>Proteins: Struct., Funct., Bioinf.</source><year>2007</year>, <volume>67</volume>, <fpage>1078</fpage>–<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1002/prot.21373</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Andrusier</surname><given-names>N.</given-names></name>; <name><surname>Nussinov</surname><given-names>R.</given-names></name>; <name><surname>Wolfson</surname><given-names>H. J.</given-names></name><article-title>FireDock: Fast interaction refinement
in molecular docking</article-title>. <source>Proteins: Struct., Funct.,
Bioinf.</source><year>2007</year>, <volume>69</volume>, <fpage>139</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1002/prot.21495</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Pierce</surname><given-names>B.</given-names></name>; <name><surname>Weng</surname><given-names>Z.</given-names></name><article-title>A combination of rescoring
and refinement significantly improves
protein docking performance</article-title>. <source>Proteins: Struct.,
Funct., Bioinf.</source><year>2008</year>, <volume>72</volume>, <fpage>270</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1002/prot.21920</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Su</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>A.</given-names></name>; <name><surname>Xia</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Sun</surname><given-names>Z.</given-names></name><article-title>Quantitative
prediction of protein–protein binding affinity with a potential
of mean force considering volume correction</article-title>. <source>Protein Sci.</source><year>2009</year>, <volume>18</volume>, <fpage>2550</fpage>–<lpage>2558</lpage>. <pub-id pub-id-type="doi">10.1002/pro.257</pub-id>.<pub-id pub-id-type="pmid">19798743</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Chaudhury</surname><given-names>S.</given-names></name>; <name><surname>Lyskov</surname><given-names>S.</given-names></name>; <name><surname>Gray</surname><given-names>J. J.</given-names></name><article-title>PyRosetta:
a script-based interface
for implementing molecular modeling algorithms using Rosetta</article-title>. <source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>689</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq007</pub-id>.<pub-id pub-id-type="pmid">20061306</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Ravikant</surname><given-names>D. V. S.</given-names></name>; <name><surname>Elber</surname><given-names>R.</given-names></name><article-title>PIE-efficient filters
and coarse grained potentials
for unbound protein-protein docking</article-title>. <source>Proteins</source><year>2010</year>, <volume>78</volume>, <fpage>400</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1002/prot.22550</pub-id>.<pub-id pub-id-type="pmid">19768784</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Moal</surname><given-names>I. H.</given-names></name>; <name><surname>Agius</surname><given-names>R.</given-names></name>; <name><surname>Bates</surname><given-names>P. A.</given-names></name><article-title>Protein–protein binding affinity
prediction on a diverse set of structures</article-title>. <source>Bioinformatics</source><year>2011</year>, <volume>27</volume>, <fpage>3002</fpage>–<lpage>3009</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr513</pub-id>.<pub-id pub-id-type="pmid">21903632</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Pons</surname><given-names>C.</given-names></name>; <name><surname>Talavera</surname><given-names>D.</given-names></name>; <name><surname>de la Cruz</surname><given-names>X.</given-names></name>; <name><surname>Orozco</surname><given-names>M.</given-names></name>; <name><surname>Fernandez-Recio</surname><given-names>J.</given-names></name><article-title>Scoring by
Intermolecular Pairwise Propensities of Exposed Residues (SIPPER):
A New Efficient Potential for Protein–Protein Docking</article-title>. <source>J. Chem. Inf. Model.</source><year>2011</year>, <volume>51</volume>, <fpage>370</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1021/ci100353e</pub-id>.<pub-id pub-id-type="pmid">21214199</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Viswanath</surname><given-names>S.</given-names></name>; <name><surname>Ravikant</surname><given-names>D. V. S.</given-names></name>; <name><surname>Elber</surname><given-names>R.</given-names></name><article-title>Improving
ranking of models for protein
complexes with side chain modeling and atomic potentials</article-title>. <source>Proteins: Struct., Funct., Bioinf.</source><year>2013</year>, <volume>81</volume>, <fpage>592</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1002/prot.24214</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Kastritis</surname><given-names>P. L.</given-names></name>; <name><surname>Rodrigues</surname><given-names>J. P. G. L. M.</given-names></name>; <name><surname>Folkers</surname><given-names>G. E.</given-names></name>; <name><surname>Boelens</surname><given-names>R.</given-names></name>; <name><surname>Bonvin</surname><given-names>A. M. J. J.</given-names></name><article-title>Proteins Feel More Than They See: Fine-Tuning of Binding
Affinity by Properties of the Non-Interacting Surface</article-title>. <source>J. Mol. Biol.</source><year>2014</year>, <volume>426</volume>, <fpage>2632</fpage>–<lpage>2652</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2014.04.017</pub-id>.<pub-id pub-id-type="pmid">24768922</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Vangone</surname><given-names>A.</given-names></name>; <name><surname>Bonvin</surname><given-names>A. M.</given-names></name><article-title>Contacts-based prediction of binding affinity in protein-protein
complexes</article-title>. <source>eLife</source><year>2015</year>, <volume>4</volume>, <elocation-id>e07454</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07454</pub-id>.<pub-id pub-id-type="pmid">26193119</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Huang</surname><given-names>X.</given-names></name>; <name><surname>Zheng</surname><given-names>W.</given-names></name>; <name><surname>Pearce</surname><given-names>R.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>SSIPe: accurately estimating
protein–protein binding affinity change upon mutations using
evolutionary profiles in combination with an optimized physical energy
function</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>2429</fpage>–<lpage>2437</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz926</pub-id>.<pub-id pub-id-type="pmid">31830252</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="undeclared" id="cit23"><person-group person-group-type="allauthors"><name><surname>Wang</surname><given-names>B.</given-names></name>; <name><surname>Su</surname><given-names>Z.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name></person-group><article-title>Computational Assessment of Protein–Protein
Binding Affinity by Reverse Engineering the Energetics in Protein
Complexes</article-title><source>Genomics, Proteomics Bioinf.</source><year>2021</year>, <pub-id pub-id-type="doi">10.1016/j.gpb.2021.03.004</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Abbasi</surname><given-names>W. A.</given-names></name>; <name><surname>Yaseen</surname><given-names>A.</given-names></name>; <name><surname>Hassan</surname><given-names>F. U.</given-names></name>; <name><surname>Andleeb</surname><given-names>S.</given-names></name>; <name><surname>Minhas</surname><given-names>F. U. A. A.</given-names></name><article-title>ISLAND:
in-silico proteins binding affinity prediction using sequence information</article-title>. <source>BioData Mining</source><year>2020</year>, <volume>13</volume>, <fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s13040-020-00231-w</pub-id>.<pub-id pub-id-type="pmid">33292419</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Yugandhar</surname><given-names>K.</given-names></name>; <name><surname>Gromiha</surname><given-names>M. M.</given-names></name><article-title>Protein–protein
binding affinity prediction
from amino acid sequence</article-title>. <source>Bioinformatics</source><year>2014</year>, <volume>30</volume>, <fpage>3583</fpage>–<lpage>3589</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu580</pub-id>.<pub-id pub-id-type="pmid">25172924</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Abbasi</surname><given-names>W. A.</given-names></name>; <name><surname>Asif</surname><given-names>A.</given-names></name>; <name><surname>Ben-Hur</surname><given-names>A.</given-names></name>; <name><surname>Minhas</surname><given-names>F. uA. A.</given-names></name><article-title>Learning protein
binding affinity using privileged information</article-title>. <source>BMC Bioinf.</source><year>2018</year>, <volume>19</volume>, <fpage>425</fpage><pub-id pub-id-type="doi">10.1186/s12859-018-2448-z</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Xue</surname><given-names>L. C.</given-names></name>; <name><surname>Rodrigues</surname><given-names>J. P.</given-names></name>; <name><surname>Kastritis</surname><given-names>P. L.</given-names></name>; <name><surname>Bonvin</surname><given-names>A. M.</given-names></name>; <name><surname>Vangone</surname><given-names>A.</given-names></name><article-title>PRODIGY: a
web server for predicting the binding affinity of protein–protein
complexes</article-title>. <source>Bioinformatics</source><year>2016</year>, <volume>32</volume>, <elocation-id>btw514</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btw514</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Ballester</surname><given-names>P. J.</given-names></name>; <name><surname>Mitchell</surname><given-names>J. B. O.</given-names></name><article-title>A machine learning approach to predicting
protein-ligand
binding affinity with applications to molecular docking</article-title>. <source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>1169</fpage>–<lpage>1175</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq112</pub-id>.<pub-id pub-id-type="pmid">20236947</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Jiménez</surname><given-names>J.</given-names></name>; <name><surname>Škalič</surname><given-names>M.</given-names></name>; <name><surname>Martínez-Rosell</surname><given-names>G.</given-names></name>; <name><surname>De Fabritiis</surname><given-names>G.</given-names></name><article-title>KDEEP: Protein–Ligand
Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks</article-title>. <source>J. Chem. Inf. Model.</source><year>2018</year>, <volume>58</volume>, <fpage>287</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00650</pub-id>.<pub-id pub-id-type="pmid">29309725</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Breiman</surname><given-names>L.</given-names></name><article-title>Random Forests</article-title>. <source>Mach. Learn.</source><year>2001</year>, <volume>45</volume>, <fpage>5</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010933404324</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="conf-proc" id="cit31"><person-group person-group-type="allauthors"><name><surname>LeCun</surname><given-names>Y.</given-names></name>; <name><surname>Boser</surname><given-names>B.</given-names></name>; <name><surname>Denker</surname><given-names>J.</given-names></name>; <name><surname>Henderson</surname><given-names>D.</given-names></name>; <name><surname>Howard</surname><given-names>R.</given-names></name>; <name><surname>Hubbard</surname><given-names>W.</given-names></name>; <name><surname>Jackel</surname><given-names>L.</given-names></name></person-group><source>Proceedings
of Advances in Neural
Information Processing Systems</source>, <year>1989</year>; <fpage>396</fpage>–<lpage>404</lpage>.</mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>LeCun</surname><given-names>Y.</given-names></name>; <name><surname>Bottou</surname><given-names>L.</given-names></name>; <name><surname>Bengio</surname><given-names>Y.</given-names></name>; <name><surname>Haffner</surname><given-names>P.</given-names></name><article-title>Gradient-based learning
applied to document recognition</article-title>. <source>Proc. IEEE</source><year>1998</year>, <volume>86</volume>, <fpage>2278</fpage>–<lpage>2324</lpage>. <pub-id pub-id-type="doi">10.1109/5.726791</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name><article-title>DeepMHC: Deep Convolutional Neural Networks for High-performance
peptide-MHC Binding Affinity Prediction</article-title>. <source>bioRxiv
Preprint</source><year>2017</year>, <fpage>239236</fpage><pub-id pub-id-type="doi">10.1101/239236</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Jurtz</surname><given-names>V.</given-names></name>; <name><surname>Paul</surname><given-names>S.</given-names></name>; <name><surname>Andreatta</surname><given-names>M.</given-names></name>; <name><surname>Marcatili</surname><given-names>P.</given-names></name>; <name><surname>Peters</surname><given-names>B.</given-names></name>; <name><surname>Nielsen</surname><given-names>M.</given-names></name><article-title>NetMHCpan-4.0: Improved Peptide-MHC
Class I Interaction Predictions Integrating Eluted Ligand and Peptide
Binding Affinity Data</article-title>. <source>J. Immunol.</source><year>2017</year>, <volume>199</volume>, <fpage>3360</fpage>–<lpage>3368</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700893</pub-id>.<pub-id pub-id-type="pmid">28978689</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Yang</surname><given-names>J.</given-names></name>; <name><surname>Roy</surname><given-names>A.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>BioLiP: a semi-manually
curated database for biologically
relevant ligand-protein interactions</article-title>. <source>Nucleic
Acids Res.</source><year>2012</year>, <volume>41</volume>, <fpage>D1096</fpage>–<lpage>D1103</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks966</pub-id>.<pub-id pub-id-type="pmid">23087378</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Fang</surname><given-names>X.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name><article-title>The PDBbind Database:
Collection of Binding Affinities for Protein–Ligand Complexes
with Known Three-Dimensional Structures</article-title>. <source>J.
Med. Chem.</source><year>2004</year>, <volume>47</volume>, <fpage>2977</fpage>–<lpage>2980</lpage>. <pub-id pub-id-type="doi">10.1021/jm030580l</pub-id>.<pub-id pub-id-type="pmid">15163179</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Šali</surname><given-names>A.</given-names></name>; <name><surname>Blundell</surname><given-names>T. L.</given-names></name><article-title>Comparative Protein
Modelling by Satisfaction of Spatial
Restraints</article-title>. <source>J. Mol. Biol.</source><year>1993</year>, <volume>234</volume>, <fpage>779</fpage>–<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1993.1626</pub-id>.<pub-id pub-id-type="pmid">8254673</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Fiser</surname><given-names>A.</given-names></name>; <name><surname>Do</surname><given-names>R. K.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name><article-title>Modeling of loops in protein structures</article-title>. <source>Protein Sci.</source><year>2000</year>, <volume>9</volume>, <fpage>1753</fpage>–<lpage>1773</lpage>. <pub-id pub-id-type="doi">10.1110/ps.9.9.1753</pub-id>.<pub-id pub-id-type="pmid">11045621</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Martí-Renom</surname><given-names>M.
A.</given-names></name>; <name><surname>Stuart</surname><given-names>A. C.</given-names></name>; <name><surname>Fiser</surname><given-names>A.</given-names></name>; <name><surname>Sánchez</surname><given-names>R.</given-names></name>; <name><surname>Melo</surname><given-names>F.</given-names></name>; <name><surname>Šali</surname><given-names>A.</given-names></name><article-title>Comparative
Protein Structure Modeling
of Genes and Genomes</article-title>. <source>Annu. Rev. Biophys. Biomol.
Struct.</source><year>2000</year>, <volume>29</volume>, <fpage>291</fpage>–<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biophys.29.1.291</pub-id>.<pub-id pub-id-type="pmid">10940251</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Webb</surname><given-names>B.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name><article-title>Comparative Protein
Structure Modeling Using MODELLER</article-title>. <source>Curr. Protoc.
Bioinform.</source><year>2016</year>, <volume>54</volume>, <fpage>5.6.1</fpage>–<lpage>5.6.37</lpage>. <pub-id pub-id-type="doi">10.1002/cpbi.3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Dolinsky</surname><given-names>T. J.</given-names></name>; <name><surname>Nielsen</surname><given-names>J. E.</given-names></name>; <name><surname>McCammon</surname><given-names>J. A.</given-names></name>; <name><surname>Baker</surname><given-names>N. A.</given-names></name><article-title>PDB2PQR: an automated
pipeline for the setup of Poisson-Boltzmann electrostatics calculations</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>, <volume>32</volume>, <fpage>W665</fpage>–<lpage>W667</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh381</pub-id>.<pub-id pub-id-type="pmid">15215472</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Paz</surname><given-names>W.</given-names></name>; <name><surname>Green</surname><given-names>J.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name><article-title>ProtDCal: A program to compute general-purpose-numerical
descriptors for sequences and 3D-structures of proteins</article-title>. <source>BMC Bioinf.</source><year>2015</year>, <volume>16</volume>, <fpage>162</fpage><pub-id pub-id-type="doi">10.1186/s12859-015-0586-0</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Romero-Molina</surname><given-names>S.</given-names></name>; <name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Green</surname><given-names>J. R.</given-names></name>; <name><surname>Sanchez-Garcia</surname><given-names>E.</given-names></name><article-title>ProtDCal-Suite:
A web server for the numerical codification and functional analysis
of proteins</article-title>. <source>Protein Sci.</source><year>2019</year>, <volume>28</volume>, <fpage>1734</fpage>–<lpage>1743</lpage>. <pub-id pub-id-type="doi">10.1002/pro.3673</pub-id>.<pub-id pub-id-type="pmid">31271472</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Kinjo</surname><given-names>A. R.</given-names></name>; <name><surname>Nishikawa</surname><given-names>K.</given-names></name><article-title>Recoverable one-dimensional encoding of three-dimensional
protein structures</article-title>. <source>Bioinformatics</source><year>2005</year>, <volume>21</volume>, <fpage>2167</fpage>–<lpage>2170</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti330</pub-id>.<pub-id pub-id-type="pmid">15722374</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Biggar</surname><given-names>K. K.</given-names></name>; <name><surname>Charih</surname><given-names>F.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Stalker</surname><given-names>L.</given-names></name>; <name><surname>Chopra</surname><given-names>A.</given-names></name>; <name><surname>Connolly</surname><given-names>J.</given-names></name>; <name><surname>Adhikary</surname><given-names>H.</given-names></name>; <name><surname>Frensemier</surname><given-names>K.</given-names></name>; <name><surname>Hoekstra</surname><given-names>M.</given-names></name>; <name><surname>Galka</surname><given-names>M.</given-names></name>; <name><surname>Fang</surname><given-names>Q.</given-names></name>; <name><surname>Wynder</surname><given-names>C.</given-names></name>; <name><surname>Stanford</surname><given-names>W. L.</given-names></name>; <name><surname>Green</surname><given-names>J. R.</given-names></name>; <name><surname>Li</surname><given-names>S. S. C.</given-names></name><article-title>Proteome-wide
Prediction of Lysine Methylation Leads to Identification of H2BK43
Methylation and Outlines the Potential Methyllysine Proteome</article-title>. <source>Cell Rep.</source><year>2020</year>, <volume>32</volume>, <fpage>107896</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107896</pub-id>.<pub-id pub-id-type="pmid">32668242</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name>; <name><surname>García-Hernández</surname><given-names>E.</given-names></name>; <name><surname>Green</surname><given-names>J.</given-names></name><article-title>Novel “extended
sequons” of human N-glycosylation sites
improve the precision of qualitative predictions: an alignment-free
study of pattern recognition using ProtDCal protein features</article-title>. <source>Amino Acids</source><year>2017</year>, <volume>49</volume>, <fpage>317</fpage>–<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-016-2362-5</pub-id>.<pub-id pub-id-type="pmid">27896447</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Romero-Molina</surname><given-names>S.</given-names></name>; <name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Harms</surname><given-names>M.</given-names></name>; <name><surname>Münch</surname><given-names>J.</given-names></name>; <name><surname>Sanchez-Garcia</surname><given-names>E.</given-names></name><article-title>PPI-Detect:
A support vector machine model for sequence-based
prediction of protein–protein interactions</article-title>. <source>J. Comput. Chem.</source><year>2019</year>, <volume>40</volume>, <fpage>1233</fpage>–<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.25780</pub-id>.<pub-id pub-id-type="pmid">30768790</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Ruiz-Blanco</surname><given-names>Y. B.</given-names></name>; <name><surname>Agüero-Chapin</surname><given-names>G.</given-names></name>; <name><surname>García-Hernández</surname><given-names>E.</given-names></name>; <name><surname>Álvarez</surname><given-names>O.</given-names></name>; <name><surname>Antunes</surname><given-names>A.</given-names></name>; <name><surname>Green</surname><given-names>J.</given-names></name><article-title>Exploring general-purpose
protein features for distinguishing enzymes and non-enzymes within
the twilight zone</article-title>. <source>BMC Bioinf.</source><year>2017</year>, <volume>18</volume>, <fpage>349</fpage><pub-id pub-id-type="doi">10.1186/s12859-017-1758-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Corral-Corral</surname><given-names>R.</given-names></name>; <name><surname>Beltrán</surname><given-names>J. A.</given-names></name>; <name><surname>Brizuela</surname><given-names>C. A.</given-names></name>; <name><surname>Del Rio</surname><given-names>G.</given-names></name><article-title>Systematic
Identification
of Machine-Learning Models Aimed to Classify Critical Residues for
Protein Function from Protein Structure</article-title>. <source>Molecules</source><year>2017</year>, <volume>22</volume>, <fpage>1673</fpage><pub-id pub-id-type="doi">10.3390/molecules22101673</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Kleandrova</surname><given-names>V. V.</given-names></name>; <name><surname>Ruso</surname><given-names>J. M.</given-names></name>; <name><surname>Speck-Planche</surname><given-names>A.</given-names></name>; <name><surname>Dias Soeiro Cordeiro</surname><given-names>M. N.</given-names></name><article-title>Enabling
the Discovery and Virtual Screening of Potent and Safe Antimicrobial
Peptides. Simultaneous Prediction of Antibacterial Activity and Cytotoxicity</article-title>. <source>ACS Comb. Sci.</source><year>2016</year>, <volume>18</volume>, <fpage>490</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1021/acscombsci.6b00063</pub-id>.<pub-id pub-id-type="pmid">27280735</pub-id></mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Speck-Planche</surname><given-names>A.</given-names></name>; <name><surname>Kleandrova</surname><given-names>V. V.</given-names></name>; <name><surname>Ruso</surname><given-names>J. M.</given-names></name>; <name><surname>D S Cordeiro</surname><given-names>M. N.</given-names></name><article-title>First Multitarget
Chemo-Bioinformatic Model To Enable the Discovery of Antibacterial
Peptides against Multiple Gram-Positive Pathogens</article-title>. <source>J. Chem. Inf. Model.</source><year>2016</year>, <volume>56</volume>, <fpage>588</fpage>–<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00630</pub-id>.<pub-id pub-id-type="pmid">26960000</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="undeclared" id="cit52"><person-group person-group-type="allauthors"><name><surname>Frank</surname><given-names>E.</given-names></name>; <name><surname>Hall</surname><given-names>M.
A.</given-names></name>; <name><surname>Witten</surname><given-names>I.
H.</given-names></name></person-group><source>The WEKA Workbench. Online
Appendix for ″Data Mining: Practical Machine Learning Tools
and Techniques″</source>, <year>2016</year>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Patel</surname><given-names>L.</given-names></name>; <name><surname>Shukla</surname><given-names>T.</given-names></name>; <name><surname>Huang</surname><given-names>X.</given-names></name>; <name><surname>Ussery</surname><given-names>D. W.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name><article-title>Machine Learning
Methods in Drug Discovery</article-title>. <source>Molecules</source><year>2020</year>, <volume>25</volume>, <fpage>5277</fpage><pub-id pub-id-type="doi">10.3390/molecules25225277</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Byrne</surname><given-names>R.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>S.</given-names></name><article-title>Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery</article-title>. <source>Chem. Rev.</source><year>2019</year>, <volume>119</volume>, <fpage>10520</fpage>–<lpage>10594</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00728</pub-id>.<pub-id pub-id-type="pmid">31294972</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Rodríguez-Pérez</surname><given-names>R.</given-names></name>; <name><surname>Vogt</surname><given-names>M.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name><article-title>Influence of Varying Training Set
Composition and Size on Support Vector Machine-Based Prediction of
Active Compounds</article-title>. <source>J. Chem. Inf. Model.</source><year>2017</year>, <volume>57</volume>, <fpage>710</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00088</pub-id>.<pub-id pub-id-type="pmid">28376613</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="conf-proc" id="cit56"><person-group person-group-type="allauthors"><name><surname>Nguyen</surname><given-names>A.</given-names></name>; <name><surname>Yosinski</surname><given-names>J.</given-names></name>; <name><surname>Clune</surname><given-names>J.</given-names></name></person-group> In <source>Deep Neural Networks
are Easily
Fooled: High Confidence Predictions for Unrecognizable Images</source>, 2015 IEEE Conference on Computer Vision and Pattern Recognition
(CVPR), <year>2015</year>; pp <fpage>427</fpage>–<lpage>436</lpage>.</mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Nalepa</surname><given-names>J.</given-names></name>; <name><surname>Kawulok</surname><given-names>M.</given-names></name><article-title>Selecting training
sets for support vector machines:
a review</article-title>. <source>Artif. Intell. Rev.</source><year>2019</year>, <volume>52</volume>, <fpage>857</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1007/s10462-017-9611-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Shevade</surname><given-names>S. K.</given-names></name>; <name><surname>Keerthi</surname><given-names>S. S.</given-names></name>; <name><surname>Bhattacharyya</surname><given-names>C.</given-names></name>; <name><surname>Murthy</surname><given-names>K. R. K.</given-names></name><article-title>Improvements
to the SMO algorithm for SVM regression</article-title>. <source>IEEE
Trans. Neural Networks</source><year>2000</year>, <volume>11</volume>, <fpage>1188</fpage>–<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1109/72.870050</pub-id>.<pub-id pub-id-type="pmid">18249845</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="book" id="cit59"><person-group person-group-type="allauthors"><name><surname>Kuncheva</surname><given-names>L. I.</given-names></name></person-group>, <source>Combining Pattern
Classifiers: Methods and Algorithms</source>; <publisher-name>John
Wiley &amp; Sons, Inc.</publisher-name>, <year>2004</year>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Kittler</surname><given-names>J.</given-names></name>; <name><surname>Hatef</surname><given-names>M.</given-names></name>; <name><surname>Duin</surname><given-names>R. P. W.</given-names></name>; <name><surname>Matas</surname><given-names>J.</given-names></name><article-title>On combining
classifiers</article-title>. <source>IEEE Trans. Pattern Analysis Machine
Intelligence</source><year>1998</year>, <volume>20</volume>, <fpage>226</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1109/34.667881</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="undeclared" id="cit61"><person-group person-group-type="allauthors"><name><surname>Chih-Wei</surname><given-names>H.</given-names></name>; <name><surname>Chih-Chung</surname><given-names>C.</given-names></name>; <name><surname>Chih-Jen</surname><given-names>L.</given-names></name></person-group><source>A Practical Guide to
Support Vector Classification</source>, <year>2003</year>.</mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Jankauskaitė</surname><given-names>J.</given-names></name>; <name><surname>Jiménez-García</surname><given-names>B.</given-names></name>; <name><surname>Dapku̅nas</surname><given-names>J.</given-names></name>; <name><surname>Fernández-Recio</surname><given-names>J.</given-names></name>; <name><surname>Moal</surname><given-names>I. H.</given-names></name><article-title>SKEMPI
2.0: an updated
benchmark of changes in protein–protein binding energy, kinetics
and thermodynamics upon mutation</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume>, <fpage>462</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty635</pub-id>.<pub-id pub-id-type="pmid">30020414</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Fang</surname><given-names>X.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>C.-Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name><article-title>The PDBbind
Database: Methodologies and Updates</article-title>. <source>J. Med.
Chem.</source><year>2005</year>, <volume>48</volume>, <fpage>4111</fpage>–<lpage>4119</lpage>. <pub-id pub-id-type="doi">10.1021/jm048957q</pub-id>.<pub-id pub-id-type="pmid">15943484</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Su</surname><given-names>M.</given-names></name>; <name><surname>Han</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>Q.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name><article-title>Forging the Basis for
Developing Protein–Ligand Interaction
Scoring Functions</article-title>. <source>Acc. Chem. Res.</source><year>2017</year>, <volume>50</volume>, <fpage>302</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.6b00491</pub-id>.<pub-id pub-id-type="pmid">28182403</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Zirafi</surname><given-names>O.</given-names></name>; <name><surname>Kim</surname><given-names>K.-A.</given-names></name>; <name><surname>Ständker</surname><given-names>L.</given-names></name>; <name><surname>Mohr</surname><given-names>K. B.</given-names></name>; <name><surname>Sauter</surname><given-names>D.</given-names></name>; <name><surname>Heigele</surname><given-names>A.</given-names></name>; <name><surname>Kluge</surname></name>; <name><surname>Silvia</surname><given-names>F.</given-names></name>; <name><surname>Wiercinska</surname><given-names>E.</given-names></name>; <name><surname>Chudziak</surname><given-names>D.</given-names></name>; <name><surname>Richter</surname><given-names>R.</given-names></name>; <name><surname>Moepps</surname><given-names>B.</given-names></name>; <name><surname>Gierschik</surname><given-names>P.</given-names></name>; <name><surname>Vas</surname><given-names>V.</given-names></name>; <name><surname>Geiger</surname><given-names>H.</given-names></name>; <name><surname>Lamla</surname><given-names>M.</given-names></name>; <name><surname>Weil</surname><given-names>T.</given-names></name>; <name><surname>Burster</surname><given-names>T.</given-names></name>; <name><surname>Zgraja</surname><given-names>A.</given-names></name>; <name><surname>Daubeuf</surname><given-names>F.</given-names></name>; <name><surname>Frossard</surname><given-names>N.</given-names></name>; <name><surname>Hachet-Haas</surname><given-names>M.</given-names></name>; <name><surname>Heunisch</surname><given-names>F.</given-names></name>; <name><surname>Reichetzeder</surname><given-names>C.</given-names></name>; <name><surname>Galzi</surname><given-names>J.-L.</given-names></name>; <name><surname>Pérez-Castells</surname><given-names>J.</given-names></name>; <name><surname>Canales-Mayordomo</surname><given-names>A.</given-names></name>; <name><surname>Jiménez-Barbero</surname><given-names>J.</given-names></name>; <name><surname>Giménez-Gallego</surname><given-names>G.</given-names></name>; <name><surname>Schneider</surname><given-names>M.</given-names></name>; <name><surname>Shorter</surname><given-names>J.</given-names></name>; <name><surname>Telenti</surname><given-names>A.</given-names></name>; <name><surname>Hocher</surname><given-names>B.</given-names></name>; <name><surname>Forssmann</surname><given-names>W.-G.</given-names></name>; <name><surname>Bonig</surname><given-names>H.</given-names></name>; <name><surname>Kirchhoff</surname><given-names>F.</given-names></name>; <name><surname>Münch</surname><given-names>J.</given-names></name><article-title>Discovery and Characterization of an Endogenous CXCR4
Antagonist</article-title>. <source>Cell Rep.</source><year>2015</year>, <volume>11</volume>, <fpage>737</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.061</pub-id>.<pub-id pub-id-type="pmid">25921529</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Pawig</surname><given-names>L.</given-names></name>; <name><surname>Klasen</surname><given-names>C.</given-names></name>; <name><surname>Weber</surname><given-names>C.</given-names></name>; <name><surname>Bernhagen</surname><given-names>J.</given-names></name>; <name><surname>Noels</surname><given-names>H.</given-names></name><article-title>Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand
Family: Molecular Perspectives</article-title>. <source>Front. Immunol.</source><year>2015</year>, <volume>6</volume>, <elocation-id>429</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00429</pub-id>.<pub-id pub-id-type="pmid">26347749</pub-id></mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Harms</surname><given-names>M.</given-names></name>; <name><surname>Gilg</surname><given-names>A.</given-names></name>; <name><surname>Ständker</surname><given-names>L.</given-names></name>; <name><surname>Beer</surname><given-names>A. J.</given-names></name>; <name><surname>Mayer</surname><given-names>B.</given-names></name>; <name><surname>Rasche</surname><given-names>V.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Münch</surname><given-names>J.</given-names></name><article-title>Microtiter
plate-based antibody-competition assay to determine binding affinities
and plasma/blood stability of CXCR4 ligands</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume>, <elocation-id>16036</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-73012-4</pub-id>.<pub-id pub-id-type="pmid">32994431</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Liang</surname><given-names>S.</given-names></name>; <name><surname>Meroueh</surname><given-names>S. O.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Qiu</surname><given-names>C.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name><article-title>Consensus
scoring for enriching near-native structures from protein-protein
docking decoys</article-title>. <source>Proteins</source><year>2009</year>, <volume>75</volume>, <fpage>397</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1002/prot.22252</pub-id>.<pub-id pub-id-type="pmid">18831053</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Harms</surname><given-names>M.</given-names></name>; <name><surname>Habib</surname><given-names>M. M. W.</given-names></name>; <name><surname>Nemska</surname><given-names>S.</given-names></name>; <name><surname>Nicolò</surname><given-names>A.</given-names></name>; <name><surname>Gilg</surname><given-names>A.</given-names></name>; <name><surname>Preising</surname><given-names>N.</given-names></name>; <name><surname>Sokkar</surname><given-names>P.</given-names></name>; <name><surname>Carmignani</surname><given-names>S.</given-names></name>; <name><surname>Raasholm</surname><given-names>M.</given-names></name>; <name><surname>Weidinger</surname><given-names>G.</given-names></name>; <name><surname>Kizilsavas</surname><given-names>G.</given-names></name>; <name><surname>Wagner</surname><given-names>M.</given-names></name>; <name><surname>Ständker</surname><given-names>L.</given-names></name>; <name><surname>Abadi</surname><given-names>A. H.</given-names></name>; <name><surname>Jumaa</surname><given-names>H.</given-names></name>; <name><surname>Kirchhoff</surname><given-names>F.</given-names></name>; <name><surname>Frossard</surname><given-names>N.</given-names></name>; <name><surname>Sanchez-Garcia</surname><given-names>E.</given-names></name>; <name><surname>Münch</surname><given-names>J.</given-names></name><article-title>An optimized derivative of an endogenous CXCR4 antagonist
prevents atopic dermatitis and airway inflammation</article-title>. <source>Acta Pharm. Sin. B</source><year>2021</year>, <volume>11</volume>, <fpage>2694</fpage>–<lpage>2708</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2020.12.005</pub-id>.<pub-id pub-id-type="pmid">34589390</pub-id></mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Sokkar</surname><given-names>P.</given-names></name>; <name><surname>Harms</surname><given-names>M.</given-names></name>; <name><surname>Stürzel</surname><given-names>C.</given-names></name>; <name><surname>Gilg</surname><given-names>A.</given-names></name>; <name><surname>Kizilsavas</surname><given-names>G.</given-names></name>; <name><surname>Raasholm</surname><given-names>M.</given-names></name>; <name><surname>Preising</surname><given-names>N.</given-names></name>; <name><surname>Wagner</surname><given-names>M.</given-names></name>; <name><surname>Kirchhoff</surname><given-names>F.</given-names></name>; <name><surname>Ständker</surname><given-names>L.</given-names></name>; <name><surname>Weidinger</surname><given-names>G.</given-names></name>; <name><surname>Mayer</surname><given-names>B.</given-names></name>; <name><surname>Münch</surname><given-names>J.</given-names></name>; <name><surname>Sanchez-Garcia</surname><given-names>E.</given-names></name><article-title>Computational modeling and experimental validation
of the EPI-X4/CXCR4 complex allows rational design of small peptide
antagonists</article-title>. <source>Commun. Biol.</source><year>2021</year>, <volume>4</volume>, <fpage>1113</fpage><pub-id pub-id-type="doi">10.1038/s42003-021-02638-5</pub-id>.<pub-id pub-id-type="pmid">34552197</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Clausen</surname><given-names>T.</given-names></name>; <name><surname>Southan</surname><given-names>C.</given-names></name>; <name><surname>Ehrmann</surname><given-names>M.</given-names></name><article-title>The HtrA Family of Proteases: Implications
for Protein Composition and Cell Fate</article-title>. <source>Mol.
Cell</source><year>2002</year>, <volume>10</volume>, <fpage>443</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/S1097-2765(02)00658-5</pub-id>.<pub-id pub-id-type="pmid">12408815</pub-id></mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Runyon</surname><given-names>S. T.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Appleton</surname><given-names>B. A.</given-names></name>; <name><surname>Sazinsky</surname><given-names>S. L.</given-names></name>; <name><surname>Wu</surname><given-names>P.</given-names></name>; <name><surname>Pan</surname><given-names>B.</given-names></name>; <name><surname>Wiesmann</surname><given-names>C.</given-names></name>; <name><surname>Skelton</surname><given-names>N. J.</given-names></name>; <name><surname>Sidhu</surname><given-names>S. S.</given-names></name><article-title>Structural and functional
analysis of the PDZ domains of human HtrA1 and HtrA3</article-title>. <source>Protein Sci.</source><year>2007</year>, <volume>16</volume>, <fpage>2454</fpage>–<lpage>2471</lpage>. <pub-id pub-id-type="doi">10.1110/ps.073049407</pub-id>.<pub-id pub-id-type="pmid">17962403</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>Kendall</surname><given-names>M. G.</given-names></name><article-title>A New Measure
of Rank Correlation</article-title>. <source>Biometrika</source><year>1938</year>, <volume>30</volume>, <fpage>81</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1093/biomet/30.1-2.81</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Sheridan</surname><given-names>R. P.</given-names></name><article-title>The Relative
Importance of Domain Applicability Metrics for Estimating Prediction
Errors in QSAR Varies with Training Set Diversity</article-title>. <source>J. Chem. Inf. Model.</source><year>2015</year>, <volume>55</volume>, <fpage>1098</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00110</pub-id>.<pub-id pub-id-type="pmid">25998559</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
